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ABSTRACT
The requirement of new antimicrobial treatments has become an urgent field in the last two
decades. Multi-drug resistant (MDR) bacteria are now resistant to common antibiotics such as
penicillin, cephalosporin, and carbapenems. To antagonize such bacteria 8 novel
organoantimony(V) cyanoximates were synthesized with the purpose to be characterized and
submitted for biological activity studies. The eight organoantimony(V) cyanoximates were
characterized by elemental analysis, thermal analysis, IR-, 13C{1H} NMR, some with UV-visible
spectroscopy, and single crystal X-ray analysis. Eight new crystal structures were determined.
All organoantimony(V) cyanoximates demonstrated a pentavalent coordinated distorted trigonal
bipyramid polyhedron of the Sb(V) atom. Cyanoxime anionic ligands of each determined
structure were bound to Sb(V) in a monodentate fashion. Antimicrobial Disk studies indicated
that Sb(Ph)4(ACO), Sb(Ph)4(ECO), had significant antimicrobial effect against all three strains:
two gram-negative a) Escherichia coli strain S17 and b) Pseudomonas aeruginosa strain PAO1,
alongside a single gram-positive Methicillin-resistant Staphylococcus aureus strain NRS70.
Sb(Ph)4(TCO) and Sb(Ph)4(TDCO) had significant effects on the gram- positive Methicillinresistant Staphylococcus aureus strain NRS70, but essentially no antimicrobial activity for gramnegative strains used. Antimicrobial broth dilution MIC assays were completed against the same
strains as antimicrobial disk studies but changed the compounds tested. Using Sb(Ph)4(MCO) as
the only Sb(V) cyanoximate along with the free cyanoximes H(MCO), H(ECO), and
Na[H(ACO)2]. Results indicated that free cyanoximes have no antimicrobial effect as the DMSO
solvent used in these assays contributed to the inhibition factor to the MIC of the cell cultures.
Antifungal disk assays concluded that Sb(Ph)4(ECO) was effective against Cryptococcus
neoformans and Candida albicans in a positive trend. Sb(Ph)4(TCO) followed in antifungal
activity against both strains. Sb(Ph)4(ACO) and Sb(Ph)4(TDCO) were only effective at inhibition
of Cryptococcus neoformans. Antifungal MIC assays were conducted and concluded that the free
cyanoximes had zero effect on antifungal activity against both fungi. On the other hand,
Sb(Ph)4(MCO) had shown MIC levels ranging from 10 - 50 μg/mL.
KEYWORDS: cyanoximes, organoantimony(V), antimicrobial, antifungal, antibioticresistance, X-ray single crystal analysis,
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I. INTRODUCTION

Conducted work is dedicated to the synthesis and characterization of a series of novel
organoantimony(V) compounds with oximes, and their biological activity evaluation as potential
antimicrobial and antifungal treatments.

I.1. Antibiotic Resistance
During a fifteen-year period in the 1930’s, the first clinical use of antibiotics, such as
penicillin and sulfonamide, directly decreased the mortality rate from infections in the US by
75%.1 Today, antibiotics are still the safety net between humans and harmful infections. The
Centers for Disease Control and Prevention estimates that at least 23,000 people in the U.S. die
annually by infections from antibiotic-resistance organisms.2 Gram-positive bacterial strains like
methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci
(VRE) are gaining leverage over antibiotic treatment.3 Gram negative MDR bacteria pose a
greater potential of resistance due to their multi-membrane structure, making them harder to
treat.4 This resistance poses a great enough threat, that the World Health Organization (WHO)
named antibiotic resistance as one of the three most important public health threats of the
century.5
To be able to describe the mechanisms of antibiotic resistance, it is important to
understand how antibiotics work. Antibiotics are synthesized in cells as a defense mechanism to
compete against other cells for critical nutrients and other requirements needed for survival.6
Antibiotic effects on cells can be divided into two types, bacteriostatic and bactericidal. The
former stops growth and cell division, while the latter kills the cell completely. In either case,
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antibiotics require a sufficient concentration to perform any antibiotic applications.6 In addition,
antimicrobial resistance is ancient and is the result of various interactions between organisms and
their environment. Most antimicrobial compounds are naturally produced molecules; therefore,
bacteria have evolved mechanisms against such antimicrobials for survival.7 These organisms are
coined intrinsically resistant and are not the focus of the antimicrobial resistance issue. Rather,
bacteria that were originally susceptible of antibiotic treatment but then acquired resistance is the
focus of this epidemic.

I.2. Mechanisms Of Antibiotic Resistance
Antibiotic resistance can occur via two major genetic strategies by bacteria. The first
strategy is acquisition of foreign DNA coding for resistance through horizontal gene transfer
(HGT).7 Bacteria can acquire external genetic material through three situations, a) transformation
(incorporation of naked DNA), b) transduction (phage mediated) and, c) conjugation (bacterial
“sex”).7 The second strategy revolves around the mutations of gene(s) associated with the
specific mechanism of action of the compound.7 These genetic mutations can alter the antibiotic
action of following mechanisms resulting in antimicrobial-resistance. These mechanisms
include, a) modifications of the antibiotic molecule, b) a decrease in drug uptake and increase of
efflux, c) changes of target site and, d) global changes in important metabolic pathways via
modulation of regulatory networks.6, 7 Each of these mechanisms will be further discussed below.
I.2.1. Modifications of the antibiotic molecule. This mechanism is one of the most
successful bacterial strategies to fight against the presence of antibiotics. The organism produces
enzymes that either inactivates the drug by adding specific chemical moieties to the antibiotic or
complete destruction of the antibiotic itself.7 Both situations have the antibiotic unable to bind
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with target site. In the case of chemical alterations, the production of enzymes that introduce
chemical changes to the antibiotic is well-known mechanism used by gram-positive and gramnegative bacteria. The chemical changes to these compounds are a result of enzyme-required
biochemical reactions such as acetylation, phosphorylation, and adenylation.7, 8 The resulting
effect is often correlated to steric hindrance, causing lower affinity of binding between the
antibiotic and target site. The other modification of the antibiotic molecule pertains to the
destruction of the antibiotic molecule. In the scenario of β-lactam antibiotic resistance (these
include antibiotics such as penicillin derivatives, cephems, monobactams, carbapenems, and
carbacephems) via β-lactamases, these enzymes destroy the amide bond of the β-lactam ring,
inactivating the drug. 6, 9, 10
I.2.2. Decrease Of Drug Uptake And Increase Of Efflux. Most antibiotics have targets
located inside the bacterial cell; therefore, the antibiotic compound must penetrate the outer
and/or cytoplasmic membrane in order to use its antimicrobial effect.7 Bacteria have created a
defense mechanism to prevent the uptake of antibiotics through the modification of porins.
Porins are water diffusion channels that allow passage through the outer membrane of gramnegative bacteria.11 Porin modifications that lead to a decrease in permeability, hence increasing
antibiotic resistance include, a) shifts in the type of porins expressed, b) changes in level of porin
expressed, and c) impairment of porin function. 7 If a bacterium has allowed antibiotic inside the
cell, efflux pumps are used to extrude toxic compounds as a form of antibiotic resistance. One of
the first efflux pumps described 12 a system with encoded plasmids, RP1, R222, R144, and RA1,
used to facilitate extrusion of tetracycline out of E. coli. Since that study, many efflux pumps
have been discovered and characterized in both gram-positive and gram-negative bacteria. These
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systems can be substrate specific (i.e. tetracycline) or broad substrate specificity seen in MDR
bacteria.7, 14
I.2.3. Changes in target sites. This mechanism is a common strategy for bacteria to
acquire resistance as it avoids the antimicrobial effect by interfering with the target site of the
antibiotic. There are a couple pathways in which interreference of the target site can occur. The
first pathway is through target protection. This protection is caused by inhibition of the target site
with specific proteins used in elongation factors in protein synthesis 14 which “protects” the
target site from the antibiotic. The second pathway modifies the target site to lower the affinity
of binding between the antibiotic and target site. These target site changes include, a) point
mutations in the genes encoding the target site, b) modification due to enzymatic reactions, c)
replacement or bypass of the original target. 7
I.2.4. Resistance due to global cell adaptations. The final mechanism discussed is
developed by bacteria that need to cope with certain environmental stressors and pressures in
order to survive hostile environments, such as the human body. If bacteria are inside host, the
bacteria organisms are attacked by the hosts immune system. For these bacteria to survive, they
need to adapt and cope with such stressful situations. These pathogens have created very
complex mechanisms to remove the interference with crucial cellular processes like cell wall
synthesis and membrane homeostasis.6, 7

I.3. Further Complications With Antibiotic Resistance
The resistance of MDRs can also be attributed towards the environmental exposure
caused by malpractice of qualified and unqualified medical practitioners and the patients that
receive antibiotic treatment. Whether it is a physician prescribing antibiotic indiscriminately or
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patients disobeying prescription plans, both lead to the increase of resistant microbes. The
misuse of antibiotic treatment causes the exposure of more than 15 million kilograms of
antibiotics annually in the US alone.4
Research and development for new antibiotic drugs have been terminated by most
pharmaceutical companies.3 As a result, there has been a 90% decline in novel FDA approved
antibiotics in the past 30 years.15 The emergence of bacterial antibiotic resistance is considered
an epidemic. Suggested by a report, antibiotic resistance is estimated to cause roughly 300
million premature deaths by 2050, with a loss of up to $100 trillion to the global economy.16
There will be a time soon where antibiotic treatment will cease to defend humanity against these
microbes. Therefore, a novel non-antibiotic treatment towards harmful bacteria must be found.

I.4. Drug Discovery And The Search For New Antimicrobial Agents
As stated previously, there is a growing problem for discovering new chemical
compounds that are not only better antimicrobials, but do not originate from conventional
antibiotic families. Simple small molecules such as organic compounds from different classes
received a large amount of screening and preliminary assessment, but all failed due to intrinsic
toxicity to mammals. Difficulties in modification of these organic compounds to tailor desired
stability and solubility, result in prohibitive costs. The studied classes of organic compounds
were heterocycles, aromatics, porphyrins/phthalocyanines,17 carbohydrates,18 and small peptides.
Joseph Lister introduced phenol as a form of sterilization in surgery,19 while some halogenated
compounds - chloramines – have been shown to express antibacterial properties.20-22
Among classic antimicrobial inorganic compounds a large variety of silver (I), 23
mercury(I), 24 copper(II), 25 and zinc(II) 26 complexes were studied. Other than some silver(I)
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derivatives, no elements were successfully applied as effective antimicrobial treatments. For
example, silver(I) has been used in wound treatment fabric, as a colloidal solution for topical
applications. Other silver-based compounds and compositions have various infection reducing
properties. Silver alloys, silver oxides, and silver sulfadiazine are coated on surfaces of various
implants, such as urinary and central venous catheters.27-29 Other disinfection applications of
silver(I) are silver-silica nanorattles used in implant cavity disinfection,30 and silver ions
dispersed on a proprietary polymer for disinfection of ventilator endotracheal tubes.31
Silver antimicrobial applications have been on the rise due to the increasing issue of
MDR bacteria. A main contributor towards use of silver antimicrobials is their lower toxicity
towards human cells and tissues.32 Silver has shown to exhibit strong bacteriostatic and
bactericidal effects, which are correlated by its interactions with bacterial DNA and deactivation
of bacterial respiration enzymes.33 Studies have also indicated that silver ion interactions can
contribute to the generation of reactive oxygen species (ROS).34, 35 In the case of silver
nanoparticles (AgNPs), there is evidence of direct interaction with the cell surface, allowing
penetration through the cell membrane causing leakage and eventual cell death.36, 37 Interference
with membrane permeability and inhibition of transcription and translations have also been
reported.38, 39 Even though silver antimicrobials in clinical treatment have shown promise, there
are several hurdles with the application. The largest hurdle for silver(I) inorganic compounds
corresponds to the reduction of the metal cation to elemental Ag(0), when exposed to light and
heat.40, 41 Overall, organometallic compounds have not been thoroughly investigated as
antimicrobial agents, but they represent a suitable combination of chemical stability,
lipophilicity, and novelty. These characteristics pose a threat towards antibiotic-resistant
microbes as these bacteria have yet to develop resistance toward organometallics.
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II. LITERATURE REVIEW

II.1. Introduction Of Bioinorganic Chemistry
Bioinorganic chemistry is a young field of the science and is concerned with the roles
that inorganic elements pose in biological systems and processes.42 Metal ions can have roles
incorporated in structures, catalytic reactions, transportation (heme group with O2), or all the
above. Representation of elements found in the human body can be seen in Table 1. Bioinorganic
chemistry officially began with the revolutionary work done by Paul Ehrlich, Alfred Bertheim,
and Sahachiro Hata when they developed the first successful antimicrobial arsenic-based drug,
Salvarsan. This drug was one out of more than 300 arsenic compounds which was toxic towards
the microbe that caused syphilis, but not towards the human host. A dose response curve can be
attributed to determination of optimal concentration of doses with certain elements (Figure 1).
Studying the change in growth of cells with respect to concentration of dosage is crucial to
determine which concentrations are safe, optimal, and hazardous. In the case of antimicrobial
activity, it is important to find the ideal concentration of inhibition towards microbe growth
(Figure 2). These tools are very useful in progressing development of antimicrobial,
antibacterial, and antifungal treatments.

II.2. Antimony: Chemistry And Applications
Antimony is a metalloid chemical element with the symbol Sb and an atomic number of
51. Antimony has been known since ancient times. The element “antimony” was named around
~50 AD, where the Roman scholar Pliny gave the name stibium. The original discoverer of
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antimony is not known, but many people attribute antimony with Nicolas Lemery, a French
chemist that performed one of the earliest studies on the element. Other writings attributed to the

Table 1. Elements and weight percentages found in the human body.a

a

Data from Ref. 42.

Figure 1. An example of a dose-response curve. Copied from Ref 42.

8

Figure 2. Representation of the concentration dependence of toxic and beneficial effects of metal
ions on cell growth. Reprinted from Ref 42.
Arabic father of chemistry Jabir ibn Hayyan used the name antimonium.43 Antimony has the
electronic structure [Kr] 4d10 5s2 5p3 and has readily accessible oxidation states of -3, 0, +3, and
+5. The trivalent and pentavalent oxidation states of antimony are the most important as they are
found more commonly in nature. There are two stable isotopes of antimony, 121Sb with a natural
abundance of 57.36% and 123Sb with a natural abundance of 42.64%. There are also, 35
radioisotopes, with the longest-living isotope being 125Sb with a half-life of 2.75 years.44 As
antimony is chemically reactive, it forms numerous chemical compounds. Values of various
bond energies of electron withdrawing elements with antimony can be found in Table 2.
II.1.1. Applications of antimony. Antimony can be found naturally as sulphide and
oxide ores, which are present in two forms, stibnite (Sb2S3) and valentinite (Sb2O3).43, 45 These
ores can be found in large quantities in China, South Africa, Mexico, Bolivia, and Chile. Less
common sulfide ores include ullmanite (NiSbS), livingstonite (HgSb4S8), tetrahedrite (Cu3SbS3),
wolfsbergite (CuSbS2), and jamesonite (FePb4Sb6S14). One of the traditional treatment methods
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occurs by roasting stibnite or valentinite ore with charcoal or coke to promote a volatile oxide
fume (Sb4O6), which can then be refined into pure antimony.46 During ancient times, stibnite was
commonly used for cosmetic purposes in Egypt. The distribution of domestic antimony
consumption is estimated as follows: nonmetal products (including ceramics, glass, and rubber
products), 22%; flame retardants, 40%; and metal products, such as antimonial lead and
ammunition, 39%.47
One of the important uses of antimony metal is as a hardener in lead alloys for storage
batteries. Antimony metal has other applications in solders and other metal alloys. Some other
uses for antimony alloys include “type metal”, which is used in printing presses, bullets, and
cable sheathing.43 Stibine (SbH3), a gaseous compound used in semiconductor technology, where
the purified gas serves as a n-type dopant for silicon. One of the most commercially relevant
antimony compounds used today is the trivalent antimony trioxide Sb2O3. The compound is
processed from the metalloid and is used in polyethylene terephthalate and flame-retardant
production, and as an additive in paints, pigments, and ceramics.43 Some flame-retardant
applications are used in aircraft and automobile seat covers and children’s clothing and toys.43, 49
II.1.2. Medicinal applications of antimony. Organoantimony compounds have shown
significant antimicrobial,50 antitumor,51- 53 and antifungal activity.54, 55 Organoantimony
compounds also show antitumor activity in some diphenylorganoantimony(V) thiophosphates
such as Ph2Sb{S2- PR2} (Ph = C6H5, R = Ph, i-OC3H7) 56, 57 and methylantimony(III) complexes
like (CH3)SbL (L = derivatives of meta-substituted salicylic acid.58 Due to similarity of the
mechanism, cytostatic activity 59 is attributed to these complexes, which is correlative to
cisplatin. Furthermore, the biological toxicity of organoantimony is much less than that of Pt and
Pd in the case of anticancer
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Table 2. Bond energies between Sb and halogens, chalcogens and N - typical ligands in
organoantimony compounds taken from reference.a
______________________________________________________________________________
Sb – E
E, kcal/mol
______________________________________________________________________________
Sb-F
105 ± 23
Sb-Cl
86 ± 12
Sb-Br
75 ± 14
Sb-O
103.7 ± 10
Sb-S
90.5
Sb-Te
66.3 ± 0.9
Sb-N
110 ± 20
a

Data from Ref. 48.

substances.60 In addition, antimony compounds have been used in treatment against the parasitic
disease leishmaniasis for about a century.
Leishmaniases is caused by the protozoan parasite under the genus Leishmania which
then multiplies in certain vertebrates.61 The parasite is transmitted to humans through the bite of
sandflies that are infected. Multiple forms of the disease exist, the two most known are cutaneous
leishmaniasis (CL) the most common form and visceral leishmaniasis (VL) the most severe. The
earliest treatment reported of CL used a trivalent antimonial, tartar emetic, in 1913.62 Over a
decade after the report, tartar emetic was criticized as an antimonial due to side effects such as
heavy coughing, chest pain, and severe depression.61 In addition, the compound was found to be
very unstable in a tropical climate and highly toxic.63 The disadvantages posed by trivalent
antimonials lead to the discovery of treatment with pentavalent antimonials. These included urea
stibamine. 64,65 antimony gluconate,66 and sodium stibogluconate.67 Currently, the most
commonly used organoantimony compounds against leishmaniasis are the pentavalent sodium
antimony gluconate (Pentostam) and meglumine antimoniate (Glucantime).
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The most accepted, proposed mechanism of pentavalent antimonial is their behavior as
prodrugs. 68 The pentavalent prodrug undergoes in vivo biological reduction into a much more
active/toxic trivalent antimony. This Sb5+ to Sb3+ reduction requires thiol compounds of both
mammalian and parasitic origin. 69-71 Mammalian thiols include glutathione (GSH), cysteine
(Cys), and cysteinyl-glycine (Cys-Gly). Glutathione is the main thiol in the cytosol, while
cysteine and cysteinyl-glycine are the predominant thiols within lysosomes of mammalian cells.
72, 73

The parasitic thiol compound required is trypanothione (T(SH)2), this complex consists of

glutathione and spermidine. Intake of pentavalent antimony into parasitic cells has been
suggested to occur by monoadduct formation between Sb5+ and nucleotides.74 This can be
attributed to nucleotides containing vicinal cis-hydroxyl groups (i.e. adenosine, cytidine,
guanosine, uridine, and AMP), where binding occurs at the deprotonated hydroxyl group of the
ribose moiety.75 The complexation leads to nucleotides acting as carriers for Sb5+ into parasites
via lipophospholycan (LPG) transporter.74 Figure 3 represents the intake of metal compounds
and ions into the cell either through passive diffusion or an ion specific channel. Once inside the
parasitic cell, the application of a prodrug can proceed. The reduction can occur enzymatically
(through ACR2 or TDR1 reductase) or non-enzymatically. Once the reduction has occurred
complexation between glutathione or trypanothione.
The first site of interference is with the trypanothione/TR system. This system maintains
trypanothione in the reduced state to balance the oxidoreductive balance in the Leishmania
parasite. This balance protects the cell from oxidative stress damage, toxic heavy metals, and
delivers reducing power for DNA synthesis.76, 77 Trivalent antimonials interfere with
trypanothione metabolism by inhibiting trypanothione reductase (TR) and inducing rapid efflux
of intracellular trypanothione and glutathione into unaffected Leishmania cells which lead to
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apoptosis. The second site of attack by trivalent antimony is with the CCHC zinc finger domain.
Zinc fingers can be characterized by the coordination of zinc with several amino acid residues,
typically cysteine
and histidine. This domain has purpose in a variety of diverse functions such as DNA recognition
and replication and structure and repair,78 RNA packing, protein folding and assembly, lipid
binding, transcriptional activation, cell differentiation, cell growth, and regulation of apoptosis.79
Once trivalent antimony is bound to the zinc finger domain, promotion of efflux of Zn2+ occurs,
leading to apoptosis.80 Figure 4 illustrates the prodrug model.

Figure 3. Schematic representation of how chemical compounds enter the cell, taken from
literature. Reprinted from Ref 74.

II.3. Coordination Compounds: An Introduction
Coordination compounds, often referred to as “Werner-type” (Figure 5), contain a central
atom and ligands. The central atom is usually a metal ion, such as Cu, Ni, Fe, or metalloids, such
as Sb, As, and Ge. While the ligands can be various types of inorganic molecules such as H2O,
NH3, SO2, N2, inorganic anions (Cl-, OH-, F-, Br-, NCS-, N3-, CN-), or small organic molecules
13

(pyridine, 1,2-ethylendiamine, amino acids, etc.). In general the organic ligands can vary heavily,
but the most interesting are mixed-donor ligands, allowing the opportunity to construct new
structure with higher complexity.42 Among the latter ligands, oximes have a special role of
being: a) multidentate ligands, and b) possess biological activity. Types of oximes are shown in
Figure 6.

Figure 4. Model of pentavalent antimonials as prodrugs taken from literature. Transferred from
Ref 81.
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Figure 5. Types of bonding found in coordination and organometallic compounds.
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II.4. Cyanoximes: Ligands For Coordination Compounds
Oximes are ampolydentate organic ligands, which have known biological activity. As of
events in the Spring of 2020, there are now newly developed antiviral oxime-containing
compounds that showed activity against HIV, SARS-CoV-2, and MERS-CoV-2, which are now
in different stages of clinical trials.82 The structures of these oxime compounds are shown in
Figure 7. This ampolydentate behavior can be seen with the ACO- cyanoxime anion with various
metals (Figure 8). All cyanoximes represent not only ampolydentate ligands, but also
demonstrate rich stereochemistry. Therefore, we observed with years of study of these compouds
four distinctive geometries shown in Figure 9. Each isomer was confirmed by X-ray analysis. No
interconversion of these isomers was observed.
Cyanoximes represent a new, unique class of biologically active compounds capable of
binding to various metals.83 The general structure for cyanoximes is HO-N=C(CN)-R, where R
represents the varying electron withdrawing group, typically O, N, or S. The presence of the
electron-hungry nitrile (CN) group significantly increases the Lewis acidity making them better
ligands to bind metals ions in solution than regular monoximes.60 The nitrile group allows
deprotonation of the cyanoxime in alkaline medium very facile in aqueous and polar organic
solvents.84-86 The color originates from a ground state to a low-lying excited state n π* in the
nitroso-chromophore in the visible region of the spectrum.87-89 Figure 10 represents the
deprotonation behavior. In addition, cyanoximes have a resonance system delocalization of
charge with its anions allowing more stable structures (Figure 11).
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Figure 9. Geometrical isomers of cyanoximes.

Cyanoximes were found to have shown significant biological activity such as
antimicrobial, 93, 94 growth-regulating,95 and detoxifying agricultural pesticide properties 96
making them useful in a variety of applications. Earlier data demonstrated no intrinsic in vitro
cytotoxicity of free cyanoximes.97-99 Also, cyanoximes have shown antimicrobial activity with
some of their Ag(I) salts and the sulfur-containing thioamide-cyanoxime, HO-N=C(CN)C(S)NH2, and its K+, Na+, Cu2+, Ni2+ salts.100, 101 There are 44 known cyanoximes today (Figure
12), where eight of those ligands were selected for currents studies from the library as discussed
in Part II (Figure 13). The ligands were chosen based off known biological activity and those
with some water solubility.
The source of antimony for the organoanimtony(V) cyanoximates is from Sb(Ph)4Br. The
[Sb(Ph)4] moiety was selected due to its commercial availability as a colorless and crystalline solid
compound. We realized that the tetraphenyl antimony possesses considerable lypophilicity, but we
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needed to prove the concept that the combination of known biological cyanoxime ligands and the
[Sb(Ph)4] moiety will produce useful compounds. Regardless, it was important to develop a viable
synthetic route of organoantimony(V) cyanoximates in general. Therefore, to summarize, this
research was conducted for the purpose to try to combine the biological properties of both
organoantimony and cyanoximes ligands, in the hope development of new antimicrobial
compounds of non-antibiotic nature.

Figure 10. Deprotonation of cyanoximes with metal carbonates, hydroxides, and oxides in
aqueous and polar organic solvents.
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Figure 12. List of known cyanoximes ligands. Asterisks indicate compounds for which crystal
structures were determined.
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Figure 13. Chemical structures of selected cyanoxime ligands and their commonly used
abbreviations.
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III. RESEARCH GOALS
My work proposes novel research in Dr. N. Gerasimchuk’s lab. It was focused on the
synthesis of eight new organoantimony (V) cyanoximates with the purpose of performing
antimicrobial studies against Methicillin-resistant Staphylococcus aureus strain NRS70,
Escherichia coli strain S17, and Pseudomonas aeruginosa strain PAO1. Therefore, we wanted to
investigate the preparative and coordination chemistry of our tetraphenyl organoantimony (V) with
a group of selected cyanoximes (Figure 13). Literature review described the importance of a new
nonantibiotic treatment against resistant, harmful strains. Therefore, incorporating the medicinal
applications of antimonials and antimicrobial activity of silver(I) cyanoximes will further develop
this field of research. Hence, are the following goals for this research project:
1. To synthesize a series of eight novel compounds and conduct their characterization
using available spectroscopic methods and X-ray analysis.
2. Sumbit pure and fully characterized compounds for in vitro antimicrobial and
antifungal studies at a collaborative university – Oklahoma State University, Stillwater
(Prof. M. Patrauchan and Dr. K. Wozniak, respectively).
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IV. EXPERIMENTAL

IV.1. Experimental And Characterization Methods
IV.1.1. Reagents and general considerations. Reagent grade morpholine (C4H9NO),
toluene (C7H8), ethyl cyanoacetate (C5H7NO2), chloroform (CH3Cl), and our source of
organoantimony, Sb(C6H5)4Br at ~95% purity, was purchased from Sigma Aldrich. All other
chemicals and organic solvents – isopropyl alcohol (i-PrOH), acetonitrile (CH3CN), diethyl
ether, sodium nitrite (NaNO2), concentrated sulfuric acid (H2SO4), and concentrated hydrochloric
acid (HCl) from Fisher Scientific and sodium metal from Fluka – were of sufficient quality, and
used without additional purification.
Cyanoximes and their silver(I) derivatives selected for current studies were either taken
from a bank of ligands in Dr. Gerasimchuk’s research laboratory or obtained using published
procedures from starting substituted acetonitriles. Therefore, compounds such as H(2PCO),
Ag(3PCO), Ag(4PCO), Ag(ACO) and Ag(ECO), were used for syntheses of organoantimony(V)
cyanoximates from previous investigations1, while H(MCO) was prepared and purified in this
research. The thioamides-based cyanoximes H(TCO), H(TDCO) as well as all Tl(I)cyanoximates were prepared by Dr. Gerasimchuk in order to avoid graduate students’ exposure
to stench or toxic chemical compounds. Melting points were determined with the help of precalibrated apparatus with urea and naphthalene standards Digi-Melt (MPA106 SRS) in open
melting point capillaries, and reported without correction. Elemental analysis on C, H, N (and S
with thioamide-based cyanoximes) content was conducted at the Atlantic Microlab (Norcross,
GA).

1

Mark Whited, Daniela Marcano, Jeff Morton
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IV.1.2. Vibrational spectroscopy. The IR-spectra of all compounds reported herein
were samples of studied compounds with the help of Bruker ATR FT spectrophotometer. The
resolution was set to be 4 cm-1 with 64 scans in the range of 400 – 4000 cm-1. An atmospheric
compensation and baseline correction were applied for data treatment.
IV.1.3. UV-visible spectra. The electronic spectra of selected organoantimony(V)
cyanoximate compounds were recorded in solutions using the HP 8354 diode array UV-visible
spectrophotometer operating in the range of 200 – 1100 nm typically at room temperature. In
cases where variable temperature spectra were needed, a high precision Peltier Quantum
Northwest thermocontroller was used with 1 cm quartz cuvettes. Data of spectroscopic studies
are presented in appropriate places in the thesis.
IV.I.4. NMR spectra. The spectra were obtained on a Varian INova-400 MHz
spectrometer at room temperature in DMSO-d6 and CDCl2 solutions for 1H and 13C, respectively.
IV.1.5. X-ray crystallography. Suitable single crystals of organoantimony(V)
cyanoximates were grown at +4oC exclusively using the vapor diffusion method: acetonitrile
solutions of compounds were placed into the inner tube and vapors of anhydrous ether were used
as crystallizing agent from the outer tube with a screw cap. Normally within 2-3 weeks after
setting up, transparent, well-shaped crystals appeared on the walls in the inner tube suitable for
crystallographic studies. All crystals selected for studies were placed on plastic MiTeGen holders
attached to the copper-pin on the goniometer head of the Bruker APEX-2 diffractometer,
equipped with a SMART CCD area detector. The intensity data were collected at low
temperature. Data collection was done in  scan mode using the Mo tube (K radiation;  =
0.71073 Å) with a highly oriented graphite monochromator. Intensities were integrated from 4
series of 364 exposures, each covering 0.5o steps in  at 20 – 60 seconds of exposition time
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depending on the crystal diffracting power, with the total data set being a sphere. The space
group determination was done with the aid of the XPREP software. The absorption correction
was performed by a crystal face indexing procedure with a help of a video microscope followed
by numerical input into the SADABS program. Both cited programs are included in the Bruker
AXS software package. All structures were solved by direct methods and refined by least squares
on weighted F2 values for all reflections with I >3Ϭ(I) using the SHELXTL program. In several
structures it was possible to identify all H-atoms on the electron density map due to the high
quality of crystals. However, in some structures H-atoms were placed in calculated positions in
accordance with the hybridization state of a hosting carbon atom and were refined isotropically.
No apparent problems or complications were encountered during the structures’ solutions and
refinement as evident from very positive PLATON checkCIF reports. Values of selected bond
lengths and valence angles are presented in respective Tables following the discussion of crystal
structures. A representative drawing of the crystal structures and packing diagrams was done
using the ORTEP 3v2 and Mercury software packages. All determined crystal structures have
been deposited at CCDC (England), with PLATON checkCIF reports.
IV.1.6. Thermal Stability Studies. Thermal stability of the obtained metal complexes
was assessed using Q-600 TG/DSC analyzer (TA Instruments) under N2 flow of 100 mL/min at
10o/min heat rate. Appendix A-1 briefly explains the use of the instrument. Heating of samples
was carried out to 800oC at which the samples’ complete decomposition was attained. Some of
the results of thermal analyses studies are presented in during discussion section with the rest of
data given in Appendix B.

25

IV.2. Synthesis Of HMCO: Synthesis Of 3-Morpholin-4-yl-3-oxoproprionitrile, The HMCO
Cyanoxime Precursor, Pre-MCO
Preparation of this ligand represents a two-step procedure (Figure 14), where we used two
methods for the amide precursor preparation. The first method for synthesis of pre-MCO used
dichloromethane as the solvent, and a mixture of morpholine, ethyl cyanoacetate, and
dichloromethane 1:1:1 (gram based) was prepared in a 25 mL amber glass bottle. Nitrogen gas
was then bubbled into the solution under stirring for 10 minutes. The bottle was then capped,
wrapped in parafilm, and placed in the freezer at a temperature of 0°C until crystallization of the
target amide. Crystallization of the desired pre-MCO compound occurred between one to two
weeks. The crystals were then filtered and washed with 35 mL of toluene followed by 35 mL of
hexane and dried in a desiccator charged with concentrated sulfuric acid for a week. The yield
was 82% (1.434 g): calculations of which were based on ethyl cyanoacetate as the limiting
reagent.
A second method for the synthesis of pre-MCO used chloroform as the solvent, as a similar
procedure previously mentioned. A mixture of morpholine, ethyl cyanoacetate, and chloroform
1:1:1 (gram based) was prepared in a 25 mL amber glass bottle. Synthesis follows as previously
mentioned. Crystallization of the desired pre-MCO amide compound occurred between one to
two weeks. The crystals were filtered and then washed with 35 mL of toluene and then 35 mL of
hexane and dried in a desiccator charged with concentrated sulfuric acid for a week. The yield
was 77% (1.224 g): Similarly, calculations of yield were based on ethyl cyanoacetate as the
limiting reagent. The two methods of preparation of the pre-MCO amide compound can be found
in Figure 14A.
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IV.3. Synthesis Of H(MCO): From Its Precursor (pre-MCO)
Nitrosation of the pre-MCO was performed at room temperature by bubbling methylnitrite
in basic conditions explained in published procedures (Figure 14B).[101] Yield of the final product
was 65% (1.11 g) from 1.434g pre-MCO, mp.: 170-173 °C, and Rf = 0.36 in EtOAc/hexane = 3:1
mobile phase. The 13C{1H} NMR spectra of H(MCO) were recorded in DMSO-d6. Where the 1H
NMR, in ppm, had chemical shifts of 14.27 (OH), ring protons - 3.32 (CH2 next to O), and 2.54
(CH2 next to N). The 13C NMR chemical shifts were analogous with previous literature reported
in.101 Bands in IR spectrum of H(MCO), in cm-1, were: 3422, 2969, 2831, 2239, 1621, and 1006.
A

B

Figure 14. A, Synthesis of the H(MCO) from its precursor obtained in two different ways. B,
nistrosation of pre-MCO amide compound into protonated cyanoxime ligand.
IV.4. Synthesis Of Ag(I)L Salts From HL Acids
There were some AgL (L = cyanoxime anion ligand) available from previous
investigations in our laboratory, which were needed for organoanitmony(V) cyanoximates.
Ag(MCO) and Ag(2PCO) were prepared in this research, while all other silver(I) salts were
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retrieved from the library of compounds in our lab. Preparation of Ag(I) complexes began with
deprotonation with K2CO3, followed by coordination with Ag through addition of AgNO3
(Figure 15). The typical synthesis of silver(I) derivatives is shown as an example for only one
compound. Thus, white H(2PCO) in the amount of 0.4605 g (2.46 mmol) was dissolved in a
mixture of 10 mL of EtOH, then diluted with 10 mL of water, heated to 55°C, and then added
dropwise to a solution of 0.169 g (1.22 mmol) of K2CO3 in 10 mL of H2O. The color of the
solution immediately turned yellow signifying the presence of the nitroso anion. The reaction
mixture was placed for 2 min into an ultrasound bath to accelerate the evolution of CO2. A
solution of 0.4183 g (2.46 mmol) of AgNO3 in 10 mL of water was added dropwise under
intensive stirring to a solution of K(2PCO) above. Mixing resulted in a very fine yellow
precipitate, which after an additional 20 min of stirring was filtered, washed with three portions
of 10 mL of water, and then dried in a vacuum desiccator charged with H2SO4 (conc.) for 3 days.
Analytical data for desired Ag(MCO) and Ag(2PCO) were reported in a MS thesis from a
previous lab member 101 and published work, 102 respectively.

Figure 15. General synthesis of silver(I) salts of cyanoxime ligands from their protonated
precursor. R represents the different cyanoximes.
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IV.5. Synthesis of Sb(Ph)4L, The Metathesis Reaction
Tetraphenylantimony(V) cyanoximates were obtained using a metathesis reaction of
previously prepared Ag(I) salts and tetraphenylantimony(V) bromide described in literature
(Figure 16).60 This method was found to be the most convenient way to synthesize
organoantimony(V),60 organotellurium (IV),103 and organotin(IV) 97 compounds. The initial
compound SbPh4Br is a commericially available source of pentavalent antimony. One typical
synthesis of organoantimony(V) cyanoximates is depicted below. The preparation of
Sb(Ph)4(ACO) was conducted by adding 0.201g (0.394 mmol) of Sb(Ph)4Br to 10 mL of dry
acetonitrile (CH3CN) in a 25-mL Erlenmeyer flask then swirled until completely dissolved. Then
under a red-light emitting lamp, 0.0865g (0.414 mmol) of finely grinded, solid Ag(ACO) was
added in small portions to the flask and sonicated for five minutes for efficient mixing of this
heterogeneous reaction. Following sonication, filtration of the white AgBr precipitate was done
using two methods in the dark: a) by vacuum filtration and b) centrifugation with nylon 0.45
micron membrane, Eppendorf tubes (Figure 17).
In the vacuum filtration method, the first colorless filtrate was transferred in Erlenmeyer
flask for storage and crystal growth. The product was washed with 5 mL portions of CH3CN,
until the filtrate did not glow under UV light when spotted on a TLC plate. This technique was a
way of controlling completeness of washing our desired product while filtering out the AgBr
byproduct. Once all product was filtrated out and washed, each portion was added to the storage
flask, and put into a desiccator with paraffin until acetonitrile was evaporated. This is possible, as
paraffin wax absorbs alkanes like our solvent CH3CN. As for filtration through centrifugation,
the cloudy solution of our desired organoanimtony(V) cyanoximate and AgBr was transferred
into filtered nylon Eppendorf tubes and centrifuged in a Thermo Scientific Sorvall Legends
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Micro 17 at 10,000 rpm for three minutes. Following centrifugation, AgBr can be visibly seen at
the bottom of the Eppendorf tubes in a clear solution. The transfer of the mentioned clear
solution was placed inside a beaker and put into a desiccator with paraffin for crystallization. The
progression of centrifuge filtration for Sb(Ph)4(MCO) is shown in Figure 18. Synthesis
information regarding compounds’ color, yields, and data of elemental composition
determination presented in Table 3.

Figure 16. General synthesis of organoantimony(V) cyanoximates using the metathesis reaction
with silver(I) salts. L represents the variety of ligands chosen for study.

Figure 17. Instrumentation and accessories used for isolation of organoantimony(V) cyanoximates
from Ag(I)Br. A Thermo Scientific centrifuge (left) with filtered nylon Eppendorf tubes (right).
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Figure 18. Progression of filtration using centrifugation a homogenous mixture of Sb(Ph)4(MCO)
and AgBr in CH3CN (left), transferred into an Eppendorf tube (middle), and after centrifugation
(right).
IV.6. Synthesis Of Thioamide Sb(Ph)4L′, From TlL′ Salts
Two thioamides TCO- and TDCO- do not form Ag(I) derivatives because of the fast
decomposition reaction resulting in a black Ag2S precipitate formation. Therefore, a methathesis
reaction using TlL′ was incorporated for the thioamide containing ligands. Contrary to Ag(I)
complexes of some cyanoximes,104 Tl(I) compounds are light-stable and readily formed with
thiols and thioamides.105
For preparation of Sb(Ph)4(TCO), 0.155 g (0.304 mmol) of white Sb(Ph)4Br was
dissolved in 8 mL of CH3CN. Then 0.101 g (0.304 mmol) of a solid, yellow powder Tl(TCO)
(Figure 19) was suspended in 4 mL of CH3CN and mixed with first solution. Sonication was
used to insure proper mixing of the solution and suspension at room temperature. After 10
minutes of sonication, filtration via centrifugation went exactly as mentioned previously,
receiving a clear yellow solution and a colorless TlBr precipitate. The filtered solution was then
placed in a beaker and stored in a charged desiccator, with paraffin wax (for CH3CN absorption),
for crystallization. The crystalized product is shown in Figure 20. Thus, preparation of Sb(Ph)4L′
(L′ = TCO-, TDCO-) was accomplished using the metathesis reaction shown in Figure 21. This is
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accomplished easily as Tl(I) halides (similar to Ag(I) halides) readily precipitate in aqueous and
nonaqueous solutions. Synthesis of both thioamide containing cyanoximates follows.

Figure 19. Microscopic image of the Tl(TCO) salt.

Figure 20. Microscopic image of desired crystalline organoantimony(V) cyanoximate,
Sb(Ph)4(TCO).
As for the synthesis of Sb(Ph)4(TDCO), 0.206 g ( 0.404 mmol) of white Sb(Ph)4Br was
dissolved in 8 mL of CH3CN. Then, 0.143 g (0.404 mmol) of finely grinded, orange Tl(TDCO)
was readily dissolved in 4 mL of CH3CN. The two solutions were sonicated for 10 minutes,
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filtered via centrifuge, and left for crystallization in the same procedure as before generating a
yellow-plate crystalline product (Figure 22).

Figure 21. General synthesis of organoantimony(V) cyanoximates using the metathesis reaction
with thallium(I) salts. L’ represents the thioamide containing ligands.

Figure 22. Microscopic image of desired crystalline organoantimony(V) cyanoximate,
Sb(Ph)4(TDCO).
IV.7. Antimicrobial Studies: Kirby-Bauer Single Disk Test
The Sb(Ph)4(MCO), Sb(Ph)4(ECO), Sb(Ph)4(TCO), Sb(Ph)4(TDCO), and Sb(Ph)4(ACO)
compounds were chosen for initial inhibition zone measurements. One of the precursors of the
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metathesis reaction, Sb(Ph)4Br, was used as a control. The procedure of applying compounds to
disks follows. Using 100% cotton paper, disks were cut with a hole-punch. 25 μl aliquot samples
of three different concentrations (stock, x2, and x4 dilution factor) of compounds dissolved in
acetonitrile were transferred onto paper disks and left to dry on a Teflon surface for 20 minutes.
Following disk preparation, inhibition zone measurements were conducted at another institute,
Oklahoma State University. Methicillin-resistant Staphylococcus aureus strain NRS70,
Escherichia coli strain S17, and Pseudomonas aeruginosa strain PAO1 were used. Precultures
were prepared by inoculating 3 mL of LB medium with a strain culture. The mixture was then
incubated at 37 °C at 200 rpm for 12 hours via a Thermo scientific MaxQ 4000. Before plate
inoculation, the cultures were collected and diluted to obtain an optical density of 600 (OD600)
at 0.1. Next, 100 μl of normalized culture was spread onto LB agar plates (15 mL of LB in each
plate). 10 μl of phosphate buffered saline (PBS) was then applied on the plate followed by
placement of compound-adsorbed disks. Fully prepared plates were then incubated at 37°C for
24 hours, after incubation clearance zones were measured.

IV.8. Antimicrobial Broth Dilution Minimal Inhibition Concentration (MIC) Assays
The same strains selected in the previous antimicrobial assay were used for broth dilution
MIC studies. The strains were tested against 4 compounds: Sb(Ph)4(MCO), H(MCO), H(ECO),
and Na[H(ACO)2]. MIC assays were determined using a similar published procedure.107
Precultures of the selected strains were grown for 12 hours in Mueller Hinton broth (MHB) at
37°C 200 rpm. The four compounds previously mentioned were put into 10 different
concentrations, starting at 0 to 500 μg/mL in increments of 50. The compounds were dissolved in
DMSO ranging from 0 to 10% in increments of 1% for the gradient. The cultures were then
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normalized to an OD of 0.1 using a spectrophotometer, then 120 μL of OD 0.1 was diluted 50X.
Next, 100 μL of the dilution inoculate solution was placed into a 100 μL well plate with the
appropriate antimicrobial compound solution. The wells were then incubated again at 37°C and
200 rpm until two time intervals occurred, 6 and 24 hours. Once reaching both time slots, the
OD600 was then measured.

IV.9. Antifungal Studies: Kirby-Bauer Single Disk Test And MIC Assays
The protonated ligands Na[H(ACO)2], H(MCO), H(ECO), and the organoantimony
cyanoximate Sb(Ph)4(MCO) were chosen for inhibition zone and MIC determination assays.
Fungi used in these experiments were Cryptococcus neoformans and Candida albicans. For all
experiments, both MIC and disk diffusion, the fungi were grown in Yeast Extract-PeptoneDextrose (YDP) broth at 30°C for 16-18 hours. Then fungi were washed three times with PBS
before adjusting to required concentration for the specific assay. In the MIC assays, the media
was RPMI-MOPS, at a pH of 7.4, and with a fungal concentration of 0.5x103 cells/mL. In
addition, fungi were incubated for 48 hours at 35°C, then visually inspected the plate and took
optical density readings on a platereader to confirm visual inspection. For the disk diffusion
assays, the media was PBS and the fungal concentration used was 1x106 cells/ mL. The disk was
applied to the center of a YPD plate previously spread with the specific fungal culture. The plate
and disk were then incubated at 30°C for 48 hours, then zone of inhibition around the disk was
measured. Results of antimicrobial and antifungal studies will be presented and discussed in the
following chapters.
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Table 3. Color, yield, and elemental analysis of synthesized organoantimony(V) cyanoximates and their precursors.
Compound
pre-MCO
HMCO
Ag(MCO)

Color
white
off-white

Yield (%)
65
82

yellow

C, % Calc. (Found)

Elemental analysis, element %
H, % Calc. (Found)
N, % Calc. (Found)

S, % Calc. (Found)

-

-

-

-

-

-

-

-

28.99 (28.19)

2.78 (2.81)

14.49 (14.06)

-

Sb(Ph)4 (MCO)

colorless

90

60.81 (59.48)

4.61 (4.52)

8.86 (6.47)

-

Sb(Ph)4 (2PCO)∙H2 O

colorless

45

64.61 (64.34)

4.20 (4.07)

7.29 (7.19)

-

Sb(Ph)4 (3PCO)

colorless

84

64.61 (62.17)

4.20 (3.99)

7.29 (6.51)

-

Sb(Ph)4 (4PCO)

colorless

46

64.61 (63.93)

4.20 (3.93)

7.29 (7.31)

-

Sb(Ph)4 (ACO)

colorless

79

59.81 (58.39)

4.09 (4.16)

7.75 (7.29)

-

Sb(Ph)4 (ECO)

colorless

91

60.86 (60.59)

4.58 (4.44)

4.89 (4.94)

-

golden yellow

51

59.40 (58.84)

4.47 (4.37)

7.17 (6.20)

5.47 (4.64)

10.84 (10.77)

0.61 (0.54)

12.64 (12.71)

9.64 (9.52)

58.08 (57.93

3.97 (3.84)

7.53 (7.42)

5.74 (5.59)

Sb(Ph)4 (TDCO)
Tl(TCO)

yellow

Sb(Ph)4 (TCO)

yellow

51
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V. RESULTS AND DISCUSSION

V.1. X-Ray Single Crystal Analysis
The crystals of all complexes were successfully grown using two different methods: 1) by
slow crystallization through evaporation of a CH3CN solvent, or 2) through the vapor diffusion
when ether helped with crystallization. Most compounds were simple and easy to crystallize with
method 1, while some hard to crystalize compounds were accomplished with 2. The Sb(Ph)4L
complexes of H(2PCO), H(3PCO), H(4PCO), H(ECO), H(MCO), H(TCO), and Tl(TDCO) were
crystallized and analyzed. Most crystal structures were initially determined by Dr. Gerasimchuk,
while later determination of the full crystal report was accomplished by me for learning
purposes. The structures were solved using direct methods incorporated into the SHELXS – 2013
and refined using the Bruker SHELXTL Software Packages.108 In the case of crystal twins,
application of the detwinning procedure followed by absorption correction was accomplished
with the help of TWINABS.109 Some of the drawings of molecular structures were done with
ORTEP 3v2,110 while the other molecular structures and packing diagrams for structures were
performed using the Mercury Program.111 Below we present brief descriptions of
crystallographic results in this study. All the presented structures were assigned Cambridge
Crystallographic Data Centre (CCDC) numbers, the checkCIF reports for each structure can be
found in Appendix C 1-9.
V.1.1. Trends found in Sb(Ph)4 cyanoximates crystal structure. All tetraphenyl
organoantimony(V) cyanoximates have an Sb(V) core that adopts a distorted trigonal bipyramid
geometry. This can be seen in every Oak Ridge Thermal Ellipsoids Program (ORTEP) diagram
shown in this chapter. Coordination polyhedra of organoantimony(V) cyanoximates are similar
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to those as previously determined compounds Sb(Ph)4OCH3 and Sb(Ph)4OH referenced.60 Some
peculiarities of the pentavalent coordination can be described for each crystal structure
determined in this work. Thus, there are three phenyl rings in the equatorial position of the
distorted trigonal bipyramid, where they adopt the most sterically favored three blade propellertype configuration. These equatorial phenyl rings are also slightly tilted towards the coordinated
monodentate cyanoxime ligand bound in the axial position to the Sb(V) atom.
In total, nine crystal structures of organoantimony(V) cyanoximtes were determined. In
six cases, there were only one molecule located in the asymmetric unit (ASU), while in three
cases we observed multiple crystallographically independent molecules in the ASU. All
determined and finalized crystal structures were registered at the world-wide Cambridge
Crystallographic Data Centre (CCDC) in England. Quality of data has been verified in Holland
by using the PLATON checkCIF program and results are present in Appendix C.
V.1.2. Crystal structure of Sb(Ph)4(ACO). The Sb(Ph)4(ACO) crystal and refinement
data are presented in Table 4. The coordination compound crystallized as a clear colorless blocklike specimen. The cyanoxime moiety adopts the trans-anti conformation with respect to the
position of the N-O of the oxime and pyridyl ring along the C2-C3 bond (Figure 23).The transanti configuration agreed with previous determination of previously described Sb(Ph)4(ACO)
crystal structure determined in.60 The ACO- oxime anion is planar, signifying no dihedral angle,
and in agreement with the previously mentioned publication and other data for this ligand. In this
study a low temperature structure was the same. This crystal structure is stabilized by H-bonding
between one of the amide’s Hydrogens and the cyanoximes N from N-O-Sb (Figure 24). The
geometry of the coordination polyhedron of the Sb(V) atom was a distorted trigonal bipyramid
coordinated was observed (Figure 25). The cyano group of the oxime is linear with atoms C1 -
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C2 - N2 = 175.9° (Table 5). Bond distances for cyano group C2 - N2 = 1.144 Å, oxime group
N1-O1 = 1.337 Å, and C1 - N1 = 1.278 Å. CCDC 2011862 contains the supplementary
crystallographic data for this compound found in Appendix C-1.

Figure 23. Molecular structure and numbering scheme of principal atoms in the crystal structure
of Sb(Ph)4(ACO). An ORTEP representation at 50% thermal ellipsoid probability. H-atoms
omitted for clarity.

Figure 24. Two least obstructed views of Sb(Ph)4(ACO) showing structure stabilization through
intramolecular H-bonding of H1a and N1, A, along with the space filling model , B.
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Table 4. Crystal data and structure refinement of Sb(Ph)4(ACO).

Parameter

Sb(Ph)4 (ACO)

Emperical formula

C27 H22 N3 O2 Sb

F.W., g mol-1
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

542.22
Colorless
0.188 mm x 0.127 mm x 0.104 mm
120(2)
monoclinic
P 1 21/c 1
a = 14.8336(8)
α = 90
b = 9.9060(6)
β = 112.7130(10)
c = 17.3977(10)
γ = 90

Unit Cell volume, Å3
Z

2358.2(2)
4

Density (calc.) Mg m-3

1.527 g/cm3

Absorp. Coeff., mm-1
F(000)
Θ range, °
Index ranges

1.199
1088
1.49 to 33.02°
-22 ≤ h ≤ 22
-14 ≤ k ≤ 15
-26 ≤ l ≤ 26

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

38365
8465 [R(int) = 0.0278]
33.02° (95.0)
Multi-scan
0.880 and 0.683
8465 / 0 / 386

2

Goodness-of-fit on F
Final R indices [I > 2σ(I)]

1.172
R1 = 0.0288
wR2 = 0.0636
R1 = 0.0391
wR2 = 0.0726

R indices (all data)
-3

Largest peak/hole, e Å
Extintion coefficient

2.183 and -0.806
n/a

Structure volume, Å3 (%)

1507.5 (63.92)
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Table 5. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
Sb(Ph)4(ACO).
Bond length (Å)

Valence angle (°)

Cyanoxime:
O1 - N1 - C1 = 116.81(17)
N1 - C1 - C2 = 121.02(19)
N1 - C1 - C3 = 119.22(19)
C1 - C2 - N2 = 175.9(3)
C1 - C3 - N3 = 114.25(19)
C1 - C3 - O2 = 121.0(2)
N3 - C3 - O2 = 124.8(2)
Metal Center:
Sb1 - O1 = 2.2529(14)
C4 - Sb1 - O1 = 81.29(7)
C10 - Sb1 - O1 = 176.48(6)
C16 - Sb1 - O1 = 84.74(7)
C22 - Sb1 - O1 = 83.43(7)
C10 - Sb1 - C4 = 95.71(8)
C16 - Sb1 - C4 = 118.80(8)
C22 - Sb1 - C4 = 120.76(8)
C16 - Sb1 - C10 = 98.35(8)
C16 - Sb1 - C22 = 116.21(8)
C22 - Sb1 - C10 = 96.62(8)

C1 - C2 = 1.441(3)
N2 - C2 = 1.144(3)
C1 - C3 = 1.498(3)
C3 - O2 = 1.227(3)
C3 - N3 = 1.339(3)
O1 - N1 = 1.337(2)
N1 - C1 = 1.278(3)

Figure 25. A, analysis of the angles of the coordination polyhedron of Sb(V) in Sb(Ph)4(ACO).
B, analysis of planarity between Sb(V) core and equatorial ipso carbons of the phenyl rings.
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V.1.3. Crystal structure of Sb(Ph)4(2PCO). The Sb(Ph)4(2PCO) crystal and refinement
data are presented in Table 6. The coordination compound crystallized as a colorless block-like
specimen (Figure 26). The cyanoxime moiety adopts the trans-anti conformation with respect to
the position of the N-O of the oxime and pyridyl ring along the C2-C3 bond (Figure 27). The
trans-anti configuration does not agree with that of the free cyanoxime H(2PCO) previously
described.112 H(2PCO) and its Fe and Ni complexes.113 The oxime anion is nonplanar as there
are two planes: a) with the main cyanoxime structure O1-N1-C1-C2-N2, and b) the pyridyl ring.
These planes have a dihedral angle of 22.63°. This crystal structure is stabilized through
intramolecular short electrostatic contact from one of the hydrogen and the π-system of one of
the equatorial phenyl rings (Figure 28). The cyano group of the oxime is linear with atoms C1 C2 - N2 = 179.3° (Table 7). Bond distances for cyano group C2 - N2 = 1.147 Å, oxime group
N1-O1 = 1.336 Å, and C1 - N1 = 1.301 Å. The CCDC number for this compound is 2011861.
Quality of the obtained structure is shown in Appendix C-2.

Figure 26. Video microscope image of the crystal of Sb(Ph)4(2PCO) with indexed faces.
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Table 6. Crystal data and structure refinement of Sb(Ph)4(2PCO).

Parameter

Sb(Ph)4 (2PCO)

Emperical formula

C31 H24 N3 OSb

-1

F.W., g mol
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

576.28
Colorless
0.084 x 0.127 x 0.171
120(2)
Monoclinic
P 1 21/n 1
a = 12.6032(8)
α = 90
b = 14.4421(9)
β = 104.9640(10)
c = 14.6699(9)
γ = 90

Unit Cell volume, Å3
Z

2579.6(3)
4

Density (calc.) Mg m-3

1.484 g/cm3

Absorp. Coeff., mm-1
F(000)

1.098
1160

Θ range, °
Index ranges

1.90 to 30.57°
-18 ≤ h ≤ 18
-20 ≤ k ≤ 20
-20 ≤ I ≤ 20

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

41038
7900 [R(int) = 0.0675]
30.57° (99.7)
Multi-scan
0.9130 and 0.8340
7900/0/421

2

Goodness-of-fit on F
Final R indices [I > 2σ(I)]

1.057
R1 = 0.0445
wR2 = 0.0900
R1 = 0.0778
wR2 = 0.1098

R indices (all data)
-3

Largest peak/hole, e Å
Extintion coefficient

2.388 and -1.442
n/a

Structure volume, Å3 (%)

1623.92(62.95)
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Table 7. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
Sb(Ph)4(2PCO).
Bond length (Å)
Cyanoxime:
C1 - N1 = 1.301(4)
C1 - C3 = 1.473(5)
C2 - N2 = 1.147(5)
C3 - N3 = 1.338(4)
C7 - N3 = 1.348(5)
N1-O1 = 1.336(4)
Metal Center:
Sb - O1 = 2.226(2)

Valence angle (°)
C1 - N1 - O1 = 113.3(3)
C1 - C2 - N2 = 179.3(4)
C2 - C1 - C3 = 118.6(3)
C7 - N3 - C3 = 117.4(3)
N1 - C1 - C3 = 120.4(3)
C2 - C1 - N1 = 121.0(3)
C8 - Sb1 - O1 = 176.09(11)
C14 - Sb1 - O1 = 81.88(11)
C20 - Sb1 - O1 = 86.01(11)
C26 - Sb1 - O1 = 94.14(12)
C14 - Sb1 - C8 = 96.48(12)
C20 - Sb1 - C8 = 97.90(13)
C26 - Sb1 - C8 = 94.14(12)
C20 - Sb1 - C14 = 115.26(13)
C20 - Sb1 - C26 = 118.21(13)
C26 - Sb1 - C14 = 123.15(13)

Figure 27. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU
Sb(Ph)4(2PCO) showing the numbering of principal atoms. H-atoms are omitted for clarity.
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Figure 28. Structure of intramolecular stabilization through electrostatic contact of equatorial
phenyl ring π-system and pyridyl hydrogen of Sb(Ph)4(2PCO). Involved atoms are expressed in a
space-filling mode.
V.1.4. Crystal structure of Sb(Ph)4(3PCO). The Sb(Ph)4(3PCO) crystal and refinement
data are presented in Table 8. The coordination compound crystallized as a colorless block-like
specimen. The cyanoxime moiety adopts the trans-anti conformation with respect to the position
of the N-O of the oxime and pyridyl ring along the C2-C3 bond (Figure 29). The trans-anti
configuration agrees with previous determination of the free cyanoxime H(3PCO) previously
described.112 The oxime anion is completely planar in this structure. This crystal structure is
stabilized through intramolecular H-bonding from one of the hydrogens from the pyridyl ring
and N1 of the cyanoxime (Figure 30). The cyano group of the oxime is linear with atoms C1 - C2
- N2 = 177.3° (Table 9). Bond distances for cyano group C2 - N2 = 1.134 Å, oxime group N1O1 = 1.339 Å, and C1 - N1 = 1.295 Å. The geometry of the coordination polyhedron and off
plane trigonal distance of the distorted trigonal bipyramid polyhedron of Sb(Ph)4(3PCO) can be
seen in Figures 31-32.The CCDC number assigned for this structure is 201180, while the
checkCIF report is presented in Appendix C-3.
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Figure 29. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU
Sb(Ph)4(3PCO) showing the numbering of principal atoms.

Figure 30. The least obstructed view of the ASU of Sb(Ph)4(3PCO) showing intramolecular
electrostatic contact of the pyridyl hydrogen (H7) with the nitrogen (N1) of the cyanoximes
moiety.
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Table 8. Crystal data and structure refinement of Sb(Ph)4(3PCO).

Parameter

Sb(Ph)4 (3PCO)

Emperical formula

C31 H24 N3 OSb

F.W., g mol-1
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

576.28
Colorless
0.086 x 0.103 x 0.144
296(2)
Triclinic
P -1
a = 10.0228(4)
α = 69.3240(10)
b = 10.498(4)
β = 72.0860(10)
c = 13.8258(5)
γ = 83.9710

Unit Cell volume, Å3
Z

2579.6(3)
2

Density (calc.) Mg m-3

1.483 g/cm3

Absorp. Coeff., mm-1
F(000)

1.098
580

Θ range, °
Index ranges

1.65 to 28.00°
-13 ≤ h ≤ 13
-13 ≤ k ≤ 13
-18 ≤ I ≤ 18

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

18032
6218[R(int) =0.0263
28.00(99.9)
Multi-scan
0.7465 and 0.6966
6218/0/421

Goodness-of-fit on F2
Final R indices [I > 2σ(I)]

1.055
R1 = 0.0242
wR2 = 0.0567
R1 = 0.0278
wR2 = 0.0585

R indices (all data)
-3

Largest peak/hole, e Å
Extintion coefficient

0.598 and -0.302
n/a

Structure volume, Å3 (%)

811.86 (62.92)
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Table 9. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
Sb(Ph)4(3PCO).
Bond length (Å)
C1 - N1 = 1.295(3)
C1 - C3 = 1.466(3)
C2 - N2 = 1.134(3)
C6 - N3 = 1.318(4)
C7 - N3 = 1.318(3)
N1-O1 = 1.339(2)
Sb - O1 = 2.226(2)

Valence angle (°)
Cyanoxime:
C1 - N1 - O1 = 115.64(17)
C1 - C2 - N2 = 177.3(3)
C2 - C1 - C3 = 119.55(17)
C7 - N3 - C6 = 116.6(2)
N1 - C1 - C3 = 119.33(18)
C2 - C1 - N1 = 121.11(19)
Metal Center:
C8 - Sb1 - O1 = 85.79(6)
C14 - Sb1 - O1 = 83.77(6)
C20 - Sb1 - O1 = 86.72(6)
C26 - Sb1 - O1 = 177.39(6)
C14 - Sb1 - C8 = 123.50(7)
C20 - Sb1 - C8 = 118.71(7)
C26 - Sb1 - C8 = 92.04(7)
C20 - Sb1 - C14 = 115.89(7)
C20 - Sb1 - C26 = 95.61(7)
C26 - Sb1 - C14 = 96.23(7)

A

B

Figure 31. Geometry of the pentavalent antimony complex Sb(Ph)4(3PCO), showing a distorted
trigonal bipyramid polyhedron coordination. Important bond lengths (A) and angles (B) of
coordination are shown.

48

Figure 32. View of the off-plane distance in the distorted trigonal-bipyramid coordination
polyhedron of Sb(Ph)4(3PCO).

V.1.5. Crystal structure of Sb(Ph)4(4PCO). The Sb(Ph)4(4PCO) crystal and refinement
data are presented in Table 10. The coordination compound crystallized as a clear, colorless
block-like specimen. The oxime anion is completely planar (Figure 33). Crystal packing of this
crystal structure is stabilized by H-bonding from two separate hydrogens of two phenyl rings to a
phenyl ring and pyridyl π-system (Figure 34). The cyano group of the oxime is linear with atoms
C1 - C2 - N2 = 177.10° (Table 11). Bond distances for cyano group C2 - N2 = 1.146 Å, oxime
group N1-O1 = 1.339 Å, and C1 - N1 = 1.304 Å. The CCDC number for this compound is
2011863, while details of checkCIF report are in Appendix C-4.
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Figure 33. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU
Sb(Ph)4(4PCO) showing the numbering of principal atoms. H-atoms are omitted for clarity.

Figure 34. Packing of two structures of Sb(Ph)4(4PCO) showing stabilization short electrostatic
contact between the centers of the 4-pyridyl centroid and phenyl rings with phenyl hydrogens.
50

Table 10. Crystal data and structure refinement of Sb(Ph)4(4PCO).

Parameter

Sb(Ph)4 (4PCO)

Emperical formula

C31 H24 N3 OSb

-1

F.W., g mol
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

576.28
Colorless
0.212 x 0.228 x 0.700
120(2)
Monoclinic
P 1 21/n 1
a = 15.3351(10)
α = 90
b = 9.7845(6)
β = 108.4590(10)
c = 18.0770(11)
γ = 90

Unit Cell volume, Å3
Z

2572.8(3)
4

Density (calc.) Mg m-3

1.488 g/cm3

Absorp. Coeff., mm-1
F(000)
Θ range, °
Index ranges

1.101
1160
1.52 to 28.00°
-20 ≤ h ≤ 20
-12 ≤ k ≤ 12
-23 ≤ l ≤ 23

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

33177
6190 [R(int) = 0.0197]
28.00(100)
Multi-scan
0.8000 and 0.5130
6190/0/409

2

Goodness-of-fit on F
Final R indices [I > 2σ(I)]

1.057
R1 = 0.0213
wR2 = 0.0543
R1 = 0.0236
wR2 = 0.0556

R indices (all data)
Largest peak/hole, e Å
Extintion coefficient

-3

1.015 and -0.281
n/a

Structure volume, Å3 (%)

1640.11 (63.74)
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Table 11. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
Sb(Ph)4(4PCO).
Bond length (Å)
C1 - N1 = 1.304(2)
C1 - C3 = 1.470(2)
C2 - N2 = 1.146(2)
C5 - N3 = 1.339(2
C6 - N3 = 1.339(2)
N1-O1 = 1.3390(17)
Sb - O1 = 2.226(2)

Valence angle (°)
Cyanoxime:
C1 - N1 - O1 = 113.82(13)
C1 - C2 - N2 = 177.10(17)
C2 - C1 - C3 = 118.60(13)
C6 - N3 - C5 = 115.71(15)
N1 - C1 - C3 = 120.33(14)
C2 - C1 - N1 = 121.11(19)
Metal Center:
C8 - Sb1 - O1 = 84.25(5)
C14 - Sb1 - O1 = 178.65(5)
C20 - Sb1 - O1 = 82.58(5)
C26 - Sb1 - O1 = 84.37(5)
C14 - Sb1 - C8 = 96.82(6)
C20 - Sb1 - C8 = 121.08(6)
C26 - Sb1 - C8 = 117.11(6)
C20 - Sb1 - C14 = 97.57(6)
C20 - Sb1 - C26 = 118.25(6)
C26 - Sb1 - C14 = 94.40(6)

V.1.6. An unexpected result: crystal structure of Sb(Ph)3(ECO) μ-oxo-dimer. With
some mistakes in the world of science, sometimes a surprise can occur with failure. This is the
case with one of my early synthesis with Sb(Ph)4(ECO). By misjudging how much water was
needed for the basic solution of K2CO3 during a preparation of Ag(3PCO), it ended up
hydrolyzing Sb(Ph)4(ECO) into the [Sb(Ph)3(ECO)]2 μ-oxo-dimer which was later discovered
after solving its crystal structure (Figure 35). There is a trans-effect of the coordinated oxime that
facilitates addition of a hydroxo-group to the Sb(V) core (Figure 36A) followed by the
dimerization of the triphenyl(V) hydroxide with elimination of water (Figure 36B).
Stereospecific reactions with substitutions in the trans- position are common in inorganic and
organometallic chemistry, and well documented in chemistry of Pt(II) and other kinetically inert
metal centers.
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For the crystal structure determination, a clear colorless, prism-like specimen was
selected. The Sb(Ph)3(ECO) oxo-dimer crystal and refinement data are presented in Table 12. It
was a surprise to find out the formation of an oxygen-bridging dimeric system. This μ-oxobridge is linear as the angle of Sb1 - O1BR - Sb2 = 180.0° (Table 13). One of the interesting
features about this structure is the anionic oxime moieties are completely planar. The cyano
group is linear C1 - C2 - N2 = 177.43 Å . Bond lengths for the cyano group were C2 - N2 =
1.145 Å, oxime group N1-O1 = 1.337 Å, and C1 - N1 = 1.299 Å. As for both Sb-O bond lengths
that are incorporated into the oxo-bridge Sb1-OBr and Sb2-OBr were 1.95274 and 1.95276 Å,
respectively (Table 13). The CCDC assigned number is 2012154 for this compound. The
checkCIF report is present in Appendix C-5.

Figure 35. An ORTEP drawing at 50% thermal ellipsoids probability level for the ASU in the
structure of Sb(Ph)3(ECO) μ-oxo-dimer showing the numbering of principal atoms. H-atoms are
omitted for clarity.
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organoantimony(V) in moist conditions.
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Table 12. Crystal data and structure refinement of the Sb(Ph)3(ECO) oxo-dimer.

Parameter

Sb(Ph)4 (ECO) dimer

Emperical formula

C46 H40 N4 O7 Sb2

-1

F.W., g mol
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

1004.32
Colorless
0.180 x 0.228 x 0.984
120(2)
Triclinic
P -1
a = 9.1829(9)
α = 111.9570(10)
b = 10.0829(10)
β = 103.200(2)
c = 13.4714(16)
γ = 95.4050(10)

Unit Cell volume, Å3
Z

1103.8(2)
1

Density (calc.) Mg m-3

1.511 g/cm3

Absorp. Coeff., mm-1
F(000)
Θ range, °
Index ranges

1.277
502
1.70 to 30.51°
-13 ≤ h ≤ 13
-14 ≤ k ≤ 14
-19 ≤ l ≤ 19

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

17209
6688 [R(int) = 0.0159
30.51° (99.2)
Multi-scan
0.8030 and 0.3660
6688/0/348

2

Goodness-of-fit on F
Final R indices [I > 2σ(I)]

1.079
R1 = 0.0188
wR2 = 0.0433
R1 = 0.0206
wR2 = 0.0447

R indices (all data)
-3

Largest peak/hole, e Å
Extintion coefficient

1.545 and -0.613
n/a

Structure volume, Å3 (%)

677.92 (61.42)
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Table 13. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
Sb(Ph)3(ECO) oxo-dimer. BR denotes the bridge oxygen connecting the dimer.
Bond length (Å)
Cyanoxime:
C1 -C2 = 1.441(2)
N2 - C2 = 1.145(2)
N1 - C1 = 1.2993 (18)
N1 - O1 = 1.3370 (15)
C1 - C3 = 1.488(2)
Metal Center:
O1BR-Sb1 = 1.95274(16)
O1BR-Sb2 = 1.95276 (16)

Valence angle (°)
N2 - C2 - C1 = 177.43(17)
C1 - N1 - O1 = 115.11(12)
N1 - C1 - C2 = 122.83(13)

Sb1 - O1BR - Sb2 = 180.0

V.1.7. Crystal structure of the monomeric Sb(Ph)4(ECO). Opposing the failure that
gave rise to the μ-oxo-dimer, the monomer of Sb(Ph)4(ECO) was successfully prepared and
crystallized. The crystalline compound is also a clear colorless block-like specimen. Crystal
structure of this compound is different and interesting because contrary to earlier described
structures, it contains two independent molecules in the ASU (Figure 37). The crystal packing
can be seen in Figure 38. Both molecules A and B cannot be superimposed by any symmetry
operations in this group. Therefore, they are called crystallographically independent molecules.
The Sb(V) atom is in a special position and is located directly on the only symmetry element
present in the crystal - a gliding plane (Figure 39).
Regarding the configuration of the oxime ligand, is adopts trans-anti conformation in both
structures. Structure and refinement data of the monomer crystal structure is shown in Table 14.
Molecule A has linear cyano group C1A - C2A - N2A = 179.2° (Table 15). Molecule B adopts a
linear cyano group as well with C1B - C2B - N2B = 177.5° (Table 16). Bond lengths for the
cyano group were C2A - N2A = 1.144 Å, oxime group N1A-O1A = 1.324 Å, and C1A - N1A =
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1.308 Å for molecule A, and C2B - N2B = 1.144 Å, oxime group N1B-O1B = 1.323 Å, and C1B
- N1B = 1.302 Å for molecule B. Both independent molecules have the ECO- anion with a planar
configuration cyanoximes core structure. As an interesting peculiarity, we will mention that the
C-O-C atoms of the ethoxy-group are ion plane with only the CH3 group being out of plane. We
may attribute this behavior to the demands of crystal packing. This structure has received the
CCDC number 2012153 and quality of the structure has been validated in the checkCIF report
shown in Appendix C-6.

Figure 37. An ORTEP drawing at 50% thermal ellipsoids probability level for the two
crystallographically independent molecules in the ASU of Sb(Ph)4(ECO) monomer showing the
numbering of principal atoms. H-atoms are omitted for clarity.
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Table 14. Crystal data and structure refinement of monomeric Sb(Ph)4(ECO).
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Table 15. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center
in Sb(Ph)4(ECO) molecule A.
Bond length (Å)
C1A - N1A = 1.308(6)
C1A - C3A = 1.483(7)
C2A - N2A = 1.144(8)
C3A - O3A = 1.352(8)
C4A - O3A = 1.456(7)
N1A-O1A = 1.324(5)
Sb1A - O1A = 2.373(3)

Valence angle (°)
Cyanoxime:
C1A - N1A - O1A = 116.0(4)
C1A - C2A - N2A = 179.2(6)
C2A - C1A - C3A = 118.0(4)
C3A - O3A - C4A = 115.9(5)
N1A - C1A - C3A = 119.3(5)
C2A - C1A - N1A = 122.7(5)
Metal Center:
C6A - Sb1A - O1A = 83.06(17)
C12A - Sb1A - O1A = 174.59(15)
C18A - Sb1A - O1A = 80.13(15)
C24A - Sb1A - O1A = 84.05(16)
C12A - Sb1A - C6A = 96.4(2)
C18A - Sb1A - C6A = 125.3(2)
C24A - Sb1A - C6A = 114.09(18)
C18A - Sb1A - C12A = 95.91(18)
C18A - Sb1A - C24A = 115.29(18)
C24A - Sb1A - C12A = 101.03(19)

Table 16. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
Sb(Ph)4(ECO) molecule B.
Bond length (Å)
C1B - N1B = 1.302(6)
C1B - C3B = 1.488(7)
C2B - N2B = 1.144(8)
C3B - O3B = 1.338(7)
C4B - O3B = 1.460(7)
N1B-O1B = 1.323(5)
Sb1B - O1B = 2.327(3)

Valence angle (°)
Cyanoxime:
C1B - N1B - O1B = 115.4(4)
C1B - C2B - N2B = 177.5(6)
C2B - C1B - C3B = 117.8(4)
C3B - O3B - C4B = 115.7(5)
N1B - C1B - C3B = 120.5(5)
C2B - C1B - N1B = 121.7(4)
Metal Center:
C6B - Sb1B - O1B = 82.70(16)
C12B - Sb1B - O1B = 175.94(17)
C18B - Sb1B - O1B = 81.21(16)
C24B - Sb1B - O1B = 83.28(17)
C12B - Sb1B - C6B = 100.23(19)
C18B - Sb1B - C6B = 115.2(2)
C24B - Sb1B - C6B = 115.80(19)
C18B - Sb1B - C12B = 94.96(19)
C18B - Sb1B - C24B = 123.82(19)
C24B - Sb1B - C12B = 97.86(18)
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Figure 38. Two different views of the crystal packing in the unit cell in the structure Sb(Ph)4(ECO)
molecule A (red) and molecule B (purple).

Figure 39. Two views of the crystal packing in the unit cell Sb atom on a special position gliding
plane. Independent molecules A and B are drawn in different colors for clarity.
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V.1.8. Crystal structure of Sb(Ph)4(MCO). For structure determination of this compound a
clear, colorless, block-like crystal was selected. Similarly to the previous structure, in the
structure of Sb(Ph)4(MCO) it was found to include two crystallographically independent
molecules in the ASU which we also labeled as A and B (Figure 40) . The crystal and refinement
data for this structure are presented in Table 17. Different from most of the solved crystal
structures, around half of the hydrogen atoms were found isotropically, the rest were attached
based on hybridization states with carbon atoms. The cyanoximes moieties of molecules A and B
are nonplanar. The morpholyl groups in molecules A and B adopted the chair conformation for
stability. In both cases, the cyanoximes moieties in molecules A and B are heavily non-planar
and their dihedral angles between the cyanoxime and amide fragments are 43.99° and 47.31° for
A and B, respectively. This situation is different from other previously described Sb(V)cyanoximates with ACO- and isomeric pyridyl-cyanoximes.
This compound is an example of a classical molecular crystallography, which only relies
on van-der-Waals interactions in crystal packing. Molecules A and B have linear cyano group
Bond lengths for the cyano group were C2A - N2A = 1.141 Å, oxime group N1A-O1A = 1.353
Å, and C1A - N1A = 1.289 Å for molecule A (Figure 41), and C2B - N2B = 1.157 Å, oxime
group N1B-O1B = 1.339 Å, and C1B - N1B = 1.289 Å with molecule B (Table 18-19). The
CCDC has assigned the number 2012156 for this structure. Quality of crystal data for this
compound are presented in Appendix C-7.
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Table 17. Crystal and refinement data for the crystal Sb(Ph)4(MCO).

Parameter

Sb(Ph)4 (MCO)

Emperical formula

C31 H28 N3 O3 Sb

-1

F.W., g mol
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

612.31
Colorless
0.120 X 0.120 X 0.140
100(2)
Monoclinic
P 1 21/c 1
a = 17.6451(4)
α = 90
b = 10.8777(3)
β = 94.8360(10)
c = 28.3876(7)
γ = 90

Unit Cell volume, Å3
Z

5429.3(2)
8

Density (calc.) Mg m-3

1.498 g/cm3

Absorp. Coeff., mm-1
F(000)
Θ range, °
Index ranges

1.054
2480
1.16 to 26.52°
-22 ≤ h ≤ 22
-13 ≤ k ≤ 13
-35 ≤ I ≤ 35

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

75269
11251 [R(int) = 0.0612]
26.52° (99.8)
Multi-scan
0.8840 and 0.8670
11251 / 0 / 750

2

Goodness-of-fit on F
Final R indices [I > 2σ(I)]

1.114
R1 = 0.0447
wR2 = 0.1034
R1 = 0.0584
wR2 = 0.1109

R indices (all data)
-3

Largest peak/hole, e Å
Extintion coefficient

2.081 and -0.653
n/a

Structure volume, Å3 (%)

1623.92(62.95)
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Figure 40. Two independent molecules in the ASU of the structure of Sb(Ph)4(MCO); and ORTEP
drawing at 50% thermal ellipsoids probability level. Principal atoms are labeled, with H atoms are
omitted for clarity.
Table 18. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
the first independent molecule A, in the ASU of Sb(Ph)4(MCO).
Bond length (Å)
C1A - N1A = 1.289(5)
C1A - C3A = 1.496(6)
C2A - N2A = 1.141(6)
C3A - O2A = 1.240(5)
C3A - N3A = 1.337(6)
N1A-O1A = 1.353(5)

Sb1A - O1A = 2.260(3)

Valence angle (°)
Cyanoxime:
C1A - N1A - O1A = 114.8(4)
C1A - C2A - N2A = 178.6(6)
C2A - C1A - C3A = 115.2(4)
C1A - C3A - O2A = 116.6(4)
N1A - C1A - C3A = 122.2(4)
C2A - C1A - N1A = 122.3(4)
O2A - C3A - N3A = 122.6(5)
Metal Center:
C8A - Sb1A - O1A = 83.12(13)
C14A - Sb1A - O1A = 177.76(12)
C20A - Sb1A - O1A = 83.17(13)
C26A - Sb1A - O1A = 85.89(13)
C14 - Sb1A - C8A = 97.40(16)
C20A - Sb1A - C8A = 113.89(16)
C26A - Sb1A - C8A = 123.77(15)
C20A - Sb1A - C14A = 94.64(15)
C20A - Sb1A - C26A = 119.19(16)
C26A - Sb1A - C14A = 95.59(15)
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Table 19. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
the second independent molecule B, in the ASU of Sb(Ph)4(MCO).
Bond length (Å)

Valence angle (°)

Cyanoxime:
C1B - N1B = 1.289(5)
C1B - N1B - O1B = 115.3(4)
C1B - C3B = 1.493(7) C1B - C2B - N2B = 178.4(5)
C2B - N2B = 1.157(6) C2B - C1B - C3B = 117.1(4)
C3B - O2B = 1.233(5) C1B - C3B - O2B = 118.4(4)
C3B - N3B = 1.343(6) N1B - C1B - C3B = 119.1(4)
N1B-O1B = 1.339(5)
C2B - C1B - N1B = 123.3(4)
O2B - C3B - N3B = 123.2(5)
Metal Center:
Sb1B - O1B = 2.241(3) C8B - Sb1B - O1B = 81.09(13)
C14B - Sb1B - O1B = 175.06(13)
C20B - Sb1B - O1B = 86.79(13)
C26B - Sb1B - O1B = 84.06(14)
C14B - Sb1B - C8B = 94.05(15)
C20B - Sb1B - C8B = 120.45(16)
C26B - Sb1B - C8B = 116.21(16)
C20B - Sb1B - C14B = 96.53(15)
C20B - Sb1B - C26B = 120.11(15)
C26B - Sb1B - C14B = 97.35(16)

Figure 41. Molecular structure and labeling of principal atoms in the structure of Sb(Ph)4(MCO)
molecule A on the left, and some selected important bond lengths on the right.
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V.1.9. Crystal structure of Sb(Ph)4(TCO), two polymorphs. There were two different
polymorphs of the Sb(Ph)4(TCO) obtained from the system involving the TCO- anion and
Sb(Ph)4+ cation: polymorph 1 and polymorph 2. The first contains two independent molecules in
the ASU and crystallizes in the standard P21/ c monoclinic space group (Table 20). The second
one contains eight independent molecules in the ASU and crystallizes in the Cc monoclinic space
group (Table 21). The difference between these two systems generating 2 different polymorphs
are the conditions of crystallization. Polymorph 1 was obtained after slow evaporation of the
solvent CH3CN in a charged desiccator with paraffin. Utilizing this method of crystallization,
crystals were obtained in a week. Polymorph 2 was collected through means of vapor diffusion
when ether vapors assisted crystallization by pushing the compound from the CH3CN solution to
the walls of the inner tube. The second method, using vapor diffusion, afforded suitable crystals
for the X-ray analysis of crystals over a two-month period for crystal growth.
Polymorph 1. The coordination compound crystallized as a clear, yellow-bronze, platelike specimen (Figure 42). The Sb(Ph)4(TCO) was discovered to have in both cases unusual
geometry of the thio-oxime. In polymorph 1 there are two co-crystallized diastereomers, transanti and trans-syn, in the asymmetric unit (ASU) in the structure (Figure 43). The crystal and
refinement data of this complex is shown in Table 20. The ratio between both diastereomers was
found to be 81.7 and 18.3%, respectively (Figure 44). In both diastereomers, the TCOcyanoxime ligand are practically planar. In the case of the trans-anti isomer, the first plane
consists of every atom in the cyanoxime moiety except the amide electron withdrawing group
(C3-N3-H3B) giving a small dihedral angle of 7.42°. The trans-syn isomer is a bit different in
terms of what creates the planes of non-planarity. The first plane consists of O1A-N1A-N2A-
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C2A-C1A-C3A, the second follows with the sulfur and nitrogen of the amide (S1A-N3A-H3A1).
These two planes intersect forming a dihedral angle of 17.27°.
Another representation of the Sb(V) coordinated distorted trigonal bipyramid polyhedron
can be seen in Figure 45. The trans-anti isomer has a linear cyano group C1 - C2 - N2 = 175.6°
(Table 21). The trans-syn isomer owns a linear cyano group with C1a - C2a - N2a = 173.0°
(Table 21). Bond lengths for the cyano group were C2 - N2 = 1.140 Å, oxime group N1-O1 =
1.345 Å, and C1 - N1 = 1.266 Å for the trans-anti diastereomer, and C2a - N2a = 1.15 Å, oxime
group N1a-O1a = 1.273 Å, and C1a - N1a = 1.33 Å with the syn diastereomer. This structure
received the CCDC number 2012155, and its quality is assessed in the checkCIF report in
Appendix C-8.

Figure 42. Video microscope image of the crystal of Sb(Ph)4(TCO), polymorph 1, with indexed
faces.
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Table 20. Crystal and refinement data for the crystal Sb(Ph)4(TCO), polymorph 1.

Parameter

Sb(Ph)4 (TCO)

Emperical formula

C27 H21 N3 OSb

-1

F.W., g mol
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

557.28
light yellow-bronze
0.142 x 0.148 x 0.167
120(2)
Monoclinic
P 1 21/c 1
a = 14.6709(7)
α = 90
b = 9.8468(5)
β = 111.9940(10)
c = 18.3414(9)
γ = 90

Unit Cell volume, Å3
Z

2456.8(2)
4

Density (calc.) Mg m-3

1.507 g/cm

Absorp. Coeff., mm-1
F(000)
Θ range, °
Index ranges

3

1.232
1116
2.30 to 27.20°
-18 ≤ h ≤ 18
-12 ≤ k ≤ 12
-23 ≤ l ≤ 23

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

29603
5476 [R(int) = 0.0351]
27.20(99.9)
Multi-scan
0.8440 and 0.8210
5476 / 0 / 391

2

Goodness-of-fit on F
Final R indices [I > 2σ(I)]

1.033
R1 = 0.0308
wR2 = 0.0715
R1 = 0.0397
wR2 = 0.0764

R indices (all data)
-3

Largest peak/hole, e Å
Extintion coefficient

1.245 and -0.614
n/a

Structure volume, Å3 (%)

1614.42 (65.71)
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Table 21. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center
in the co-crystallized diastereomers of polymorph 1 of Sb(Ph)4(TCO) polymorph 1, trans-anti
(top) and trans-syn (bottom).

Bond length (Å)
C1 - N1 = 1.266(5)
C1 - C3 = 1.480(5)
C2 - N2 = 1.140(7)
C3 - S1 = 1.636(5)
C3 - N3 = 1.336(5)
N1-O1 = 1.345(4)

Sb1 - O1 = 2.304(2)

C1a - N1a = 1.33(2)
C1a - C3a = 1.44(3)
C2a - N2a = 1.15(3)
C3a - S1a = 1.82(3)
C3a - N3a = 1.27(3)
N1a-O1a = 1.273(19)

Sb1 - O1a = 2.370(14)

Valence angle (°)
Cyanoxime:
C1 - N1 - O1 = 113.9(17)
C1 - C2 - N2 = 175.6(5)
C2 - C1 - C3 = 119.2(3)
C1 - C3 - S1 = 121.9(3)
N1 - C1 - C3 = 118.9(4)
C2 - C1 - N1 = 121.9(3)
S1 - C3 - N3 = 124.1(3)
Metal Center:
C4 - Sb1 - O1 = 84.23(10)
C10 - Sb1 - O1 = 176.86(9)
C16 - Sb1 - O1 = 83.09(10)
C22 - Sb1 - O1 = 79.91(10)
C10 - Sb1 - C4 = 97.81(10)
C16 - Sb1 - C4 = 116.60(10)
C22 - Sb1 - C4 = 122.04(10)
C16 - Sb1 - C10 = 98.06(10)
C16 - Sb1 - C22 = 116.18(10)
C22 - Sb1 - C10 = 96.97(10)
Cyanoxime:
C1a - N1a - O1a = 113.9(17)
C1a - C2a - N2a = 173.(2)
C2a - C1a - C3a = 121.7(18)
C1a - C3a - S1a = 111.8(17)
N1a - C1a - C3a = 128.(2)
C2a - C1a - N1a = 109.9(19)
S1a - C3a - N3a = 123.1(16)
Metal Center:
C4 - Sb1 - O1a = 78.3(3)
C10 - Sb1 - O1a = 164.1(4)
C16 - Sb1 - O1a = 70.7(3)
C22 - Sb1 - O1a = 98.1(4)
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Figure 43. Two co-crystallized diastereomers, trans-syn and trans-anti, of the structure of
Sb(Ph)4(TCO) polymorph 1; an ORTEP drawing at 50% thermal ellipsoids probability level.
Principal atoms are labeled.

Figure 44. Two least obstructed views of the two diastereomers of Sb(Ph)4(TCO) in the ASU
representing H bonding stability between the amide hydrogen (N-H3a) and O1a. Ratios of
diastereomers are shown.
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Figure 45. Geometry of the pentavalent antimony complex Sb(Ph)4(TCO) diastereomers, showing
a distorted trigonal bipyramid polyhedron coordination. Important bond lengths and angles of
coordination are shown.
Polymorph 2. This crystalline compound formed as yellow almost square plates. A
specimen with dimensions of 0.080 mm x 0.110 mm x 180 mm was selected for crystallographic
work. We assigned it as polymorph 2. Contrary to the previous polymorph the ASU of
polymorph 2 contained eight individual molecules as only one diastereomer, trans-syn (Figure
46). This is a unique occurrence, as the unit cell volume is incredibly larger, 19k Å3 compared to
the previous 2.5k Å3 to be precise (Table 22)! With a Z value of 4, this contributes 32 molecules
in one unit cell.
The lone diastereomer, trans-syn, stabilizes its structure through intramolecular Hbonding between the one of the equatorial phenyl ring’s and amide’s hydrogen to the only
oxygen from the cyanoxime (Figure 47). The numbering scheme in the structure consisted of A,
B, C, D, E, F, H, and Q independent molecules. Representation of molecule Q will be used for
bonds and angles as an example. Other seven individual molecules can be retrieved from the
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CCCDC number 2012157 and seen in Appendix C-9. The diastereomer has a linear cyano group
C1Q - C2Q - N2Q = 175.1° (Table 23). Bond lengths for the cyano group were C2Q - N2Q =
1.151 Å, oxime group N1Q-O1Q = 1.315 Å, and C1Q - N1Q = 1.339 Å found in Table 23. Every
individual molecule was found to be nonplanar in the cyanoxime anion. All of which had the
same position of planes in the cyanoxime structure with the first plane being made up from N3C3-S1A from the thioamide. The second plane consisted of N2-C2-O1-N1-C1. All dihedral
angles from each individual molecule can be found with some statistical analysis in Table 24.
This table also includes the bond lengths of Sb-O and angles, followed by analysis of off-plane
Sb(V) core distance from the 3 ipso equatorial carbons of the phenyl rings.

Figure 46. Molecular structure and numbering scheme for principal atoms in the one of the eight
individual molecules in the ASU for the structure Sb(Ph)4(TCO) polymorph 2. An adoption of the
trans-syn configuraton by the cyanoxime moiety is shown.
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Table 22. Crystal and refinement data for another polymorph of crystalline Sb(Ph)4(TCO)
polymorph 2.

Parameter

Sb(Ph)4 (TCO) polyorph 2

Emperical formula

C216 H176 N24 O8 S8 Sb8

F.W., g mol-1
Color
Crystal size, mm
Temperature, K
Crystal system
Space group, #
Unit cell, Å,°

4466.28
fluorescent light colorless
0.080 x 0.110 x 0.180
100(2)
Monoclinic
C1c1
a = 24.517(4),
α = 90
b = 24.448(4),
β = 101.670(2)
c = 32.958(5),
γ = 90

Unit Cell volume, Å3
Z

19346.(5)
4
-3

3

Density (calc.) Mg m

1.533 g/cm

-1

Absorp. Coeff., mm
F(000)
Θ range, °
Index ranges

1.252
8960
1.19 to 29.48°
-33 ≤ h ≤ 33
-33 ≤ k ≤ 33
-45 ≤ I ≤ 43

Structure solution
Reflections collected
Indpendent reflections
Completeness to Θ, (%)
Aborption correction
Tmax and Tmin
Refinement method
Data/restraints/parameters

145367
49604 [R(int) = 0.0558]
29.48(94.3)
Multi-scan
0.9120 and 0.8160
49604 / 2 / 2379

Goodness-of-fit on F2
Final R indices [I > 2σ(I)]

1.047
R1 = 0.0569
wR2 = 0.1386
R1 = 0.0691
wR2 = 0.1472

R indices (all data)
Largest peak/hole, e Å-3
Extintion coefficient

5.682 and -2.056
n/a

3

Structure volume, Å (%)

12444.5 (64.3)
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Table 23. Selected bond lengths (Å) and angles (°) of the cyanoxime and metal complex center in
Sb(Ph)4(TCO) polymorph 2 of the 8th independent molecule in the ASU, labeled as Q.
Bond length (Å)

Valence angle (°)
Cyanoxime:
C1Q - N1Q = 1.339(13) C1Q - N1Q - O1Q = 118.2(9)
C1Q - C3Q = 1.486(15) C1Q - C2Q - N2Q = 175.1(11)
C2Q - N2Q = 1.151(14) C2Q - C1Q - C3Q = 118.3(9)
C3Q - S1Q = 1.687(10) C1Q - C3Q - S1Q = 120.0(7)
C3Q - N3Q = 1.326(13) N1Q - C1Q - C3Q = 127.8(9)
N1Q - O1Q = 1.315(11) C2Q - C1Q - N1Q = 113.8(9)
S1Q - C3Q - N3Q = 123.1(9)
Metal Center:
Sb1Q - O1Q = 2.430(7) C4Q - Sb1Q - O1Q = 176.6(3)
C10Q - Sb1Q - O1Q = 83.2(3)
C16Q - Sb1Q - O1Q = 81.4(3)
C22Q - Sb1Q - O1Q = 81.7(3)
C10Q - Sb1Q - C4Q = 99.7(4)
C16Q - Sb1Q - C4Q = 98.8(4)
C22Q - Sb1Q - C4Q = 95.3(4)
C16Q - Sb1Q - C10Q = 116.5(4)
C16Q - Sb1Q - C22Q = 117.9(4)
C22Q - Sb1Q - C10Q = 120.0(3)

Table 24. Analysis of bond lengths, bond and dihedral angles of the eight independent molecules
of the Sb(Ph)4(TCO) polymorph 2 ASU.
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Figure 47. Structure of the Q (or 8th) different polymorph shown of Sb(Ph)4(TCO) with
representation of H-bonding between the amide and phenyl hydrogen’s with the oxygen from the
oxime moiety.
V.2. Differential Scanning Calorimetry – Thermal Gravimetry Analysis (DSC/TGA)
This method was used to aseess compounds’ thermal stability and determine accurate
phase transitions. The DSC-TGA analysis of the Sb(V) cyanoximates are described Table 25. A
typical thermogram of the Sb(Ph)4(ECO) monomer shows an endothermicpeak of heat flow at
144.7°C representing and endothermic effect due to melting point (Figure 48). Every other
thermogram contributing to Table 25 can be found in Appendix B, Figures B-1 to B-6.
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Figure 48. Traces of weight loss (green) and heat flow (blue for the Sb(Ph)4(ECO) monomer
showing the melting point of the compound at 144°C followed by its decomposition.
V.3. Vibrational Spectroscopy: Infrared Spectroscopy
Assignments of vibrations were completed on all synthesized organoantimony(V)
cyanoximates and can be found in Table 26. For a majority of assignments referenced from,60, 112
but for the low cm-1 bands for Sb-Ph vibrations literature 114, 115 were used.
V.4. NMR Spectroscopy – 13C{1H} Results
All NMR spectra were recorded at room temperature for most of the organoantimony(V)
cyanoximates except Sb(Ph)4(TDCO) and Sb(Ph)4(ACO). The 13C{1H} chemical shifts of these
complexes can be found in Tables 27-28 below, along with Figure 49 demonstrating labeling on
phenyl ring. Chemical shifts were assigned based on common knowledge of chemical shifts,
previous work completed in the Dr. Gerasimchuk research group.

102, 112, 116

The technique of

13

C{1H} NMR spectroscopy is very useful as it can determine co-crystallized diastereomers , syn

and trans, by recognizing the difference in the electronic structures of individual conformations as
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two sets of resonances.117 The less favorable conformation can be found as small satellite peaks
close to the main signal, as there is a small difference in chemical shifts between the two isomers.
13

C{1H} NMR spectra can be used as a good approximation for the ratio between the two

diastereomers and can be coupled with crystallography to clearly identify the percentages of said
ratio.102 In the case of Sb(Ph)4(TCO), satellites were present in the spectra, with chemical shifts
shown in Table 28. Further investigation with 13C{1H} chemical shifts of the organoantimony(V)
cyanoximates, specifically the pyridylcyanoximates,
Table 25. Results of thermal analysis studies of organoantimony(V) cyanoximates.

______________________________________________________________________________
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Table 26. Assignment of important vibrational frequencies (cm-1) for synthesized organoantimony(V) cyanoximates.

vibrations in cyanoxime group
Compound

C6 H5 - group and Sb-Ph vibrations

a

ν (NH2 ) ν (C≡N) ν (C=X) ν (C=N)pyr ν (C=N)ox ν (N-O) ρ (NH2 ) νas(C-H)

y(ν′1g)

v(ν8 )

Sb(Ph)4 (2PCO)

-

2213

-

1589

1463

1016

-

3094

463, 433

689

Sb(Ph)4 (3PCO)

-

2218

-

1574

1473

1065

-

3051

459, 444

687

Sb(Ph)4 (4PCO)

-

2216

-

1590

1468

1114

-

3057

454, 442, 431

687

Sb(Ph)4 (ACO) 3439, 3366 2222

1679

-

1478

1086

1580

3053

442

688

Sb(Ph)4 (ECO)

-

2217

1703

-

1477

1091

-

3052

458, 436

689

Sb(Ph)4 (MCO)

-

2223

1629

-

1497

1063

-

3061

443

690

Sb(Ph)4 (TCO) 3465, 3341 2220

889

-

1583

1067

1618

3062

450

692

Sb(Ph)4 (TDCO)
2216
973
1524
1069
3066
445
688
X = sulfur atom (for TCO and TDCO ), oxygen atom (for 2PCO , 3PCO , 4PCO , ACO , ECO , MCO ). ox – oxime, pyr – pyridine

a

77

and free cyanoximes had a correlation with the acidity of the cyanoxime ligand. Figure 50
demonstrates this relationship between the chemical shifts of the ipso carbon with pKa values.
pKa values were found from previous literature.117 This relationship can be explained by the four
inequivalent carbons found on a phenyl ring. It is important to note the pyridylcyanoximates
have different delocalization of electron density when compared to other aliphatic amide-/keto/ester-cyanoximes. Even though there are only three data points contributing to this linear
relationship, it is still evident that the chemical shift of the ipso carbon is affected differently by
each opposite axial cyanoxime ligand.

Figure 49. General Structure representing the substitution patterns for the phenyl ring of
organoanimtony(V) cyanoximates. L = ligands and Br, in the case of Sb(Ph)4Br.
Table 27. Tabulated chemical shifts of 13C{1H} NMR spectroscopy for the Sb(Ph)4Br and
organoantimony(V) cyanoximates’ equivalent phenyl rings.

Compound

Assigned peak signals (ppm)
ipso
ortho
meta

para

Sb(Ph)4Br

135.38

135.04

129.44

131.15

Sb(Ph)4(ECO)

133.97

135.57

129.207

136.96

Sb(Ph)4(2PCO)

135.79

135.65

129.02

130.54

Sb(Ph)4(3PCO)

131.53

135.48

129.17

130.75

Sb(Ph)4(4PCO)

129.01

135.54

129.12

149.69

Sb(Ph)4(MCO)

134.9

135.59

129.2

130.9

Sb(Ph)4(TCO)

133.45

135.34

129.52

131.29
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Table 28. Tabulated values of chemical shifts oforganoantimony(V) cyanoximates in the 13C{1H}
NMR spectra.
Compound

δ (ppm)

Structure

Sb(Ph)4(2PCO)

Sb(Ph)4(3PCO)

Sb(Ph)4(4PCO)

79

C1
C2
C3
C4
C5,C6,C7

112.03
132.38
152.24
148.79
135.79
122.46
118.24

C1
C2
C3
C4
C5
C6,C7

111.55
128.52
127.99
149.05
145.76
129.17;
123.09

C1
C2
C3
C4,4'
C5,5'

111.56
150.15
140.05
118.24
149.69

Table 28 (continued).

Compound

δ (ppm)

Structure

Sb(Ph)4(ECO)

C1
C2
C3
C4
C5

112.03
132.38
152.24
148.79
135.79

Sb(Ph)4(MCO)

C1
C2
C3
C4
C5
C6
C7

127.87
111.54
159.99
46.60
43.02
66.53
68.97

Sb(Ph)4(TCO)
trans-anti

C1
C2
C3

110.92
131.63
190.01

Sb(Ph)4(TCO)
trans-syn

C1
C2
C3

116.92
136.38
184.98
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Figure 50. Observed correlations between acidity of the free cyanoxime HL and chemical shift of
the ipso carbon in NMR spectra of organoantimony(V) cyanoximates.
V.5. UV-Visible Spectroscopy
All obtained organoanimtony(V) cyanoximates represent colorless compounds with the
exception of Sb(Ph)4(TCO) and Sb(Ph)4(TDCO). Those exceptions are yellow colored, because
the color of the thio-cyanoxime ligands. In the UV-visible spectra bands of π  π* transitions of
the phenyl groups in all studied compounds at ~270 nm dominate the spectrum and there are no
bands in the visible range of the spectrum. As we established earlier by the X-ray analysis, the
cyanoxime ligands are bound to the Sb-atom in a monodentate manner. Compounds are soluble
in a variety of solvents and form molecular solutions with no electrical conductivity. With a
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research goal of performing biological activity studies in mind, it was important to assess the
compounds’ integrity in solutions formed.
The method of UV-visible spectroscopy is a good tool for such this task, as anionic
cyanoximes possess color. Therefore, there is a distinctive gain of color upon deprotonation of a
protonated cyanoxime ligand, HL (L = ACO-, ECO-, 2PCO-, 3PCO-, 4PCO-, and MCO-)
expressed in Figure 10. If our newly prepared Sb(Ph)4L compounds would undergo a solvolytic
reaction or dissociate in solutions, then a color will appear shown as in Figure 51. The yellow,
orange, or pink color of the cyanoximes anions originates from n  π* transition that is sensitive
to the nature of solvent.118

colorless

yellow / pink colored

solvent or T

+
Sb

Sb

+

_

L

L
O

CN
N
L

=

N

CN
N

N O-

2PCO,

CN

N O3PCO,

N O4PCO

H2N
O
ACO

CN

N

N O-

O

CN
N

O-

MCO

Figure 51. Representation of the color gain of solutions of organoantimony(V) cyanoximates in
the case of the compounds covalent integrity breaking down.
We performed recordings of the UV-visible spectra of colorless organoantimony(V)
cyanxoimates in DMSO at room temperature, increasing up to 90°C in 10° intervals. Results
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evidenced the absence of appreciable ionization of cyanoximes in solutions even at elevated
temperatures (Figure 52 and 53). Therefore, all observed in biological studies effects can be
associated with the molecular structure of the parent compound Sb(Ph)4L ( L = studied
cyanoximes anion) and not to separate Sb(Ph)4+ and L- ions. Of course, there are metabolic
processes using biochemical interactions with degradation of our Sb(Ph)4L in microorganisms,
but these investigations were out of the scope of current work.

o
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Figure 52. An overlay of fragments of the UV-visible spectra of SbPh4(2PCO) in DMSO at
different temperatures, representing reversible equilibrium of covalent to ionic bonding of Sb(V)
complex.
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Figure 53. An overlay of fragments of the UV-visible spectra of SbPh4(4PCO) in propionitrile at
different temperatures, representing reversible equilibrium of covalent to ionic bonding of Sb(V)
complex.
V.6. Antimicrobial Studies
These assays were performed by Prof. Marianna Patrauchan and her research group,
except the preparation of soaked 100% disks, which was prepared by me. The compounds
selected for each assay are explained below in each sub-chapter of results. Minimal inhibition
concentration (MIC) samples were dissolved DMSO solutions of the compounds selected prior
to testing. The results for the two sets of inhibition zone measurements and single set of minimal
inhibition concentration (MIC) assays are described below.
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V.6.1. First set of inhibition measurements on solid media. Initial compounds selected
for susceptibility tests were: Sb(Ph)4(ACO), Sb(Ph)4(ECO) monomer, Sb(Ph)4(TCO), and
Sb(Ph)4(TDCO). These compounds were tested against gram-negative strains Escherichia coli
strain S17 and Pseudomonas aeruginosa strain PAO1, alongside gram-positive Methicillinresistant Staphylococcus aureus strain NRS70. In this initial test, zone inhibition measurements
for Sb(Ph)4(TDCO) were omitted as the PBS buffer was contaminated, results for this
compounds were completed in the following round of testing. Figures 54-56 represent the first
triplicate set of inhibition zone measurements for antimicrobial activity determination. In the
case of Sb(Ph)4(ACO), it showed a trend against all strains of increased clearance zone inhibition
as Sb(V) cyanoximate concentration increased (Figure 54). This can be said for the
Sb(Ph)4(ECO) monomer for S. aureus and E .coli, but did not keep that trend against P.
aeruginosa. Finally, Sb(Ph)4(TCO) demonstrated the decent inhibition against S. aureus, but no
inhibition at all against P. aeruginosa and E. coli. Full worksheets including statistical analysis
of the first round of susceptibility tests can be found in Appendix D-1 to D-3.

Figure 54. Round 1 of Inhibition zone measurements of Sb(Ph)4(ACO) against microbes.
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Figure 55. Round 1 of Inhibition zone measurements of Sb(Ph)4(ECO) against microbes.

Figure 56. Round 1 of inhibition zone measurements of Sb(Ph)4(TCO) against microbes.

V.6.2. Second set of inhibition measurements. The second round of susceptibility tests
added a new compound, a control Sb(Ph)Br (labeled as CC# in Figure 57), and restarted
measurements with Sb(Ph)4(TDCO) due to previous contamination of PBS in the experiment.
Each were run in triplicate at three different concentrations. The measurements can be found in
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Figure 57. Essentially the same outcome occurred for Sb(Ph)4(ACO), Sb(Ph)4(ECO), and
Sb(Ph)4(TCO) as the first round of tests. For Sb(Ph)4Br there was no inhibition against P.
aeruginosa, and some inhibition against E. coli.. An interesting outcome is the inhibition zone
of Sb(Ph)4Br with respect to S. aureus. A possible reason for this outcome could be due to an
ionic halogen exposure to gram-positive bacteria which has less intrinsic defenses as grampositive bacteria lack a second cell membrane. A similar result with the first round, both of the
thioamide cyanoximates, Sb(Ph)4(TCO) and Sb(Ph)4(TDCO), only had antimicrobial effect
against the gram-positive S. aureus . The result of zone inhibition being present in only the grampositive S. aureus might show that there an instrinsic antimicrobial resistance against thioamidecontaining organoantimony cyanoximates, though more testing needs to be conducted. Raw data
and statistical analysis of this data can be found in under Appendix D-4
V.6.3. Initial broth dilution MIC tests. Initial compounds selected for antimicrobial
MIC tests were: Sb(Ph)4(MCO), H(MCO), H(ECO), and Na[H(ACO)2]. The goal of this testing
was to determine if free cyanoximes had any effect on inhibition cell growth of the same strains
tested in the inhibition zone measurements, as well as testing out an organoantimony(V)
cyanoximate. As these compounds were dissolved in DMSO, it must be reiterated that the
organic solvent has inhibition effects already once concentrations reach above 5% (Appendix D1). This inhibition concentration with DMSO would require 200 μg/mL for P. aeruginosa and
250 μg/mL for both E. coli and S. aureus.
Results of the antimicrobial MIC assays are shown in Figure 58 and 59. It is evident in MIC at
both the 6 and 24 hours marks that Sb(Ph)4(MCO) had inhibition of cell growth before the
DMSO inhibition level at 5%. Sb(Ph)4(MCO) had a definite antimicrobial effect on E. coli and S.
aureus at 200 μg/mL concentration. Compared with P. aeruginosa, some inhibition was seen

87

once concentration was increased. Switching over to the free cyanoximes, the inhibition of cells
was clearly due to DMSO concentration increasing as the interval from switching to a
concentration of zero to 100 μg/mL demonstrated negligible decrease of OD600, therefore an
indirect method to quantify microbe concentration. What is a significant factor to free
cyanoximes not contributing towards antimicrobial activity is at 6 hours for P. aeruginosa for all
protonated ligands is the increase of concentration from zero to 100 μg/mL causing an increase
of microbe concentration. Free cyanoximes tested had no effect against the strain PAO1 of P.
aeruginosa. As for the other strains, the increasing free cyanoxime concentration had little to no
effect on inhibition of microbe growth.

V.7. Antifungal Studies
These assays were performed by Dr. Karen Wozinak and her research group. Sample
preparation was exactly the same as MIC and susceptibility assays for antimicrobial studies.
Inhibition zone measurements were completed in two parts and both will be discussed, along
with reconstituted MIC assays.
V.7.1. Kirby-Bauer disk assays. Initial antifungal studies tested a control (blank cotton
disk), Sb(Ph)4(ECO), Sb(Ph)4(ACO), Sb(Ph)4(TCO), and Sb(Ph)4(TDCO) against two strains of
fungi: Cryptococcus neoformans and Candida albicans. Disks were prepared at three different
concentrations and run in triplicate. Antifungal disk assays can be seen in Figure 60. A general
trend with Sb(Ph)4(ACO), Sb(Ph)4(ECO), Sb(Ph)4(TDCO) against Cryptococcus neoformans is
that increasing concentration has a positive effect of increasing size of inhibition zone, though
for Sb(Ph)4(TDCO), the zone of inhibition was lower at all concentrations when compared to
Sb(Ph)4(TCO) which had an opposite trend than the previous three compounds. With regard to

88

Candida albicans against our copounds, it appeared that Sb(Ph)4(ECO) had some form of
antifungal activity, but all other compounds were not promising in that field.
V.7.2. MIC antifungal activity assay. MIC assays were conducted to show a
comparative study of free cyanoximes with an organoantimony(V) cyanoximate against the same
fungi strains as disk assays. Results of initial MIC assay in singlet can be seen in Figure 61. Any
MICs at 100 μg/mL signified no inhibitory effects. This was the maximum concentration that the
lab could identify with their equipment. Considering the results of each free cyanoxime, it is a
clear statement that free
cyanoximes have no antifungal activity. On the other hand, when the MCO- cyanoxime anion
was coordinated to organoantimony(V) a clear showing of inhibition was recorded. A second run
of tests was performed with essentially the same results as the initial MIC assay, except a lower
MIC in the case of Cryptococcus neoformans (Figure 62). Regardless, if one thing is evident,
further studies must be conducted to solidify the practicality of using organoantimony (V)
cyanoximates for antifungal treatment.
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Summary of susceptibility tests with discs
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Figure 57. Round 2 of inhibition zone measurements of Sb(Ph)4Br, Sb(Ph)4(ECO), Sb(Ph)4(TCO),and Sb(Ph)4( TDCO ) against
microbes.
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Figure 58. Antimicrobial MIC determination after six hours of inoculation with antimicrobial tests.
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VI.

CONCLUSIONS AND SUMMARY

This research project has been carried out within the last three years. As the result of
conducted investigation all outlined goals at the beginning of this thesis were accomplished. More
specific outcomes are presented as chemical and biological results and listed below.
Chemical part:


Several protonated HL cyanoximes, their Ag(I) (for MCO-) and Tl(I) (for TCO-, TDCOligands) derivatives have been synthesized and characterized for the purpose of preparation
of new organoantimony(V) cyanoximate-containing compounds.



Synthesized organoantimony(V) cyanoximates were characterized by elemental analysis,
TG/DSC analysis, FT-IR, 13C{1H} NMR and, in some cases, variable temperature UVvisible spectroscopy.



Eight new crystal structures of organoantimony(V) cyanoximates were determined and one
previously described in our group compound re-examined second time at low temperature
to improve quality of its data. Eight complexes represent mononuclear molecular
organometallic compounds and one is a linear -oxo dimer with trans-positioned
cyanoxime moieties (case with ECO- ligand).



Two polymorphs were observed in the Sb(Ph)4(TCO) system and their origin relates to the
crystallization method. Three structures out of nine contain multiple crystallographically
independent molecules in the asymmetric unit (ASU): two in structures of Sb(Ph)4(ECO)
and Sb(Ph)4(MCO) and eight in the structure of second polymorph of Sb(Ph)4(TCO).



In all nine oganoantimony(V) cyanoximates central atom is in pentavalent state and has
distorted trigonal bipyramid environment comprising of four carbon atoms of the phenyl
groups and one oxygen atom of the cyanoxime anion bound to a Sb(V) center in a
monodentate manner.



All synthesized compounds are well soluble in common organic solvents and poorly
soluble in water and aqueous buffers. All solutions in organic solvents are stable over time
and demonstrate negligible dissociation due to ionization at elevated temperatures above
60oC.
Biological part:



Two kinds of antimicrobial activity tests were carried out for selected new
organoantimony(V) cyanoximates: 1) based on paper disks with solid compounds on solid
media determination of zone of inhibition, and 2) determination of the minimal inhibitory
concentration (MIC) in solutions of compounds.
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Five Sb(V) cyanoximates: Sb(Ph)4(ACO), monomeric Sb(Ph)4(ECO), Sb(Ph)4(MCO),
Sb(Ph)4(TCO), and Sb(Ph)4(TDCO) were selected at the beginning of antimicrobial and
antifungal studies via paper disk susceptibility and MIC assays. The rational for choices
were: a) ACO-, ECO- and MCO- cyanoxime anions possess some water solubility and are
rich on oxygen donor atoms; b) TCO- and TDCO- are thioamides. Therefore, there is a
chance of making structure-activity-relationship (SAR) comparing analogous oxo- and
thio- cyanoximes. The control compound was the initial Sb(Ph)4Br compound without
cyanoximes. Also, pure ligands such as H(MCO), H(ECO) and Na{H(ACO)}2 without Sbatoms were used as a second set of controls.



Antimicrobial paper disk studies indicated that Sb(Ph)4(ACO), Sb(Ph)4(ECO), have
significant antimicrobial effect against all three employed strains: two gram-negative
Escherichia coli strain S17 and Pseudomonas aeruginosa strain PAO1, alongside a single
gram-positive Methicillin-resistant Staphylococcus aureus strain NRS70.



Sb(Ph)4(TCO) and Sb(Ph)4(TDCO) had significant effects on the gram- positive
Methicillin-resistant Staphylococcus aureus strain NRS70, but essentially no antimicrobial
activity for gram-negative strains used, which we found to be very interesting.



MIC assay results indicated that free cyanoximes have no antimicrobial effect, but the
DMSO solvent used in these assays contributed to the inhibition factor to the MIC assay
on cell cultures in solutions.



Antifungal disk assays were studied with the compounds Sb(Ph)4(ACO), Sb(Ph)4(ECO),
Sb(Ph)4(TCO), and Sb(Ph)4(TDCO) against the fungi of Cryptococcus neoformans and
Candida albicans strains. Disk assays concluded that Sb(Ph)4(ECO) was effective against
Cryptococcus neoformans and Candida albicans in a positive trend. Sb(Ph)4(TCO) was the
next contributor towards antifungal activity against both strains. Sb(Ph)4(ACO) and
Sb(Ph)4(TDCO) were only effective at inhibition of Cryptococcus neoformans, while those
compounds did not contribute to any inhibition towards Candida albicans.



Antifungal MIC assays were conducted on the same strains as the disks assays and used
the same Sb(V) cyanoximate Sb(Ph)4(MCO) along with the free ligands H(MCO),
H(ECO), and Na[H(ACO)2]. Results indicated that the free, uncomplexed cyanoximes had
zero effect on antifungal activity in both replicas of the experiment. On the other hand,
Sb(Ph)4(MCO) had shown MIC levels ranging from 10 - 50 μg/mL, proving there is
antifungal activity with this organometallic complex.
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VII.

FUTURE WORK

The future of using organoantimony(V) cyanoximates as a novel treatment against drugresistant microbes and fungi is very hopeful. In terms of crystal structures, Sb(Ph)4(TDCO) can be
determined. Further antimicrobial and antifungal testing is required to understand how practical
Sb(V) cyanoximates are for treatment. Tests would include: a larger variety of ligands both free
and Sb(V) coordinated. Testing with the heterocyclic cyanoximes would also be beneficial as
expanding the library of biologically active compounds is useful. Progressing with cytotoxicity
studies of Sb(V) cyanoximates is in the future, and its result will be detrimental to the development
of this promising, new treatment. Given the positive results of certain monodentate ligands in this
work, bidentate analogues will be the next step in bringing to life the use as antimicrobials.
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APPENDICES

Appendix A. Instrumentation of TG/DSC Analysis

Appendix A-1. A – general view of the thermal analyzer showing blow torch used for crucible
cleaning and tools; B – cleaning of alumina crucible with flame; C – opened furnace view showing
two beams with alumina crucibles for differential analysis.
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Appendix B. Traces of TG/DSC analyses.

Appendix B-1. TG/DSC traces for a sample of SbPh4(2PCO) showing compounds melting with
rapidly following decomposition.

Appendix B-2. TG/DSC traces for a sample of SbPh4(4PCO) showing compounds melting
followed by decomposition.
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Appendix B-3. TG/DSC traces for a sample of SbPh4(ACO) showing compounds melting with
rapidly following decomposition.

Appendix B-4. TG/DSC traces for a sample of SbPh4(TCO) showing compounds melting with
rapidly following decomposition.
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Appendix B-5. TG/DSC traces for a sample of SbPh4(MCO) (in usable range) showing
compounds melting followed by decomposition.

Appendix B-6. TG/DSC traces for a sample of SbPh4(TDCO) (in usable range) showing
compounds melting followed by decomposition.
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Appendix C. Crystal checkCIF Reports for Studied Complexes

Appendix C-1. checkCIF-reports for Sb(Ph)4(ACO).

checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) Sb-pH4-ACO
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-ACO
Bond precision: C-C = 0.0034 A
Wavelength=0.71073
Cell:
a=14.8336(8) b=9.9060(6)
c=17.3977(10)
alpha=90
beta=112.713(1) gamma=90
Temperature: 120 K
Calculated
Reported
Volume
2358.2(2)
2358.2(2)
Space group
P 21/c
P 21/c
Hall group
-P 2ybc
-P 2ybc
Moiety formula C27 H22 N3 O2 Sb
C27 H22 N3 O2 Sb
Sum formula
C27 H22 N3 O2 Sb
C27 H22 N3 O2 Sb
Mr
542.24
542.22
Dx,g cm-3
1.527
1.527
Z
4
4
Mu (mm-1)
1.199
1.199
F000
1088.0
1088.0
F000'
1086.02
h,k,lmax
22,15,26
22,15,26
Nref
8912
8465
Tmin,Tmax
0.864,0.901
0.648,0.953
Tmin'
0.839
Correction method= # Reported T Limits:
Tmin=0.648 Tmax=0.953 AbsCorr = NUMERICAL
Data completeness= 0.950 Theta(max)= 33.019
R(reflections)= 0.0288(
wR2(reflections)= 0.0726(
7070)
8465)
S = 1.172
Npar= 386
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The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.

Alert level B
PLAT919_ALERT_3_B Reflection # Likely Affected by the Beamstop ...
Check
PLAT934_ALERT_3_B Number of (Iobs-Icalc)/Sigma(W) > 10 Outliers ..
Check

1
8

Alert level C
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....
Report
PLAT420_ALERT_2_C D-H Without Acceptor
N3
--H2N3
.
Check
PLAT971_ALERT_2_C Check Calcd Resid. Dens. 2.26A
From C5
eA-3

2.71
Please
1.62

Alert level G
PLAT164_ALERT_4_G
Note
PLAT720_ALERT_4_G
Note
PLAT883_ALERT_1_G
Do !
PLAT912_ALERT_4_G
Note
PLAT941_ALERT_3_G
Low
PLAT965_ALERT_2_G
Check
PLAT978_ALERT_2_G
Info

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.

20

Number of Unusual/Non-Standard Labels ..........

2

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflections Above STh/L=

0.600

447

Average HKL Measurement Multiplicity ...........

4.5

The SHELXL WEIGHT Optimisation has not Converged

Please

Number C-C Bonds with Positive Residual Density.

4

0 ALERT
2 ALERT
3 ALERT
oversight
7 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

1 ALERT
5 ALERT
deficient
3 ALERT
3 ALERT
0 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-ACO - ellipsoid plot
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Appendix C-2. checkCIF-reports for Sb(Ph)4(2PCO).

____________________________________________________

checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) Sb-Ph4-2pco
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-2PCO
Bond precision: C-C = 0.0044 A
Wavelength=0.71073
Cell:
a=12.6027(8) b=14.4415(10)
c=14.6694(10)
alpha=90
beta=104.9644(10) gamma=90
Temperature: 100 K
Calculated
Reported
Volume
2579.3(3)
2579.3(3)
Space group
P 21/n
P 21/n
Hall group
-P 2yn
-P 2yn
Moiety formula C31 H24 N3 O Sb
C31 H24 N3 O Sb
Sum formula
C31 H24 N3 O Sb
C31 H24 N3 O Sb
Mr
576.29
576.28
Dx,g cm-3
1.484
1.484
Z
4
4
Mu (mm-1)
1.098
1.098
F000
1160.0
1160.0
F000'
1158.02
h,k,lmax
15,18,18
15,18,18
Nref
5461
5458
Tmin,Tmax
0.846,0.912
0.872,0.949
Tmin'
0.829
Correction method= # Reported T Limits:
Tmin=0.872 Tmax=0.949 AbsCorr = NUMERICAL
Data completeness= 0.999 Theta(max)= 26.710
R(reflections)= 0.0329(
wR2(reflections)= 0.0792(
4414)
5458)
S = 1.039
Npar= 421
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The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.

Alert level C
PLAT094_ALERT_2_C
Report
PLAT245_ALERT_2_C
Ang**2
PLAT245_ALERT_2_C
Ang**2
PLAT350_ALERT_3_C
Ang.
PLAT975_ALERT_2_C
eA-3

Ratio of Maximum / Minimum Residual Density ....

3.47

U(iso) H7

Smaller than U(eq) C7

by

0.013

U(iso) H24

Smaller than U(eq) C24

by

0.012

.

0.84

Short

C-H (X0.96,N1.08A)

Check Calcd Resid. Dens.

C22
1.06A

- H22
From O1

0.43

Alert level G
PLAT164_ALERT_4_G
Note
PLAT883_ALERT_1_G
Do !
PLAT912_ALERT_4_G
Note
PLAT965_ALERT_2_G
Check
PLAT978_ALERT_2_G
Info

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.

24

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflections Above STh/L=

0.600

3

The SHELXL WEIGHT Optimisation has not Converged

Please

Number C-C Bonds with Positive Residual Density.

7

0 ALERT
0 ALERT
5 ALERT
oversight
5 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

1 ALERT
6 ALERT
deficient
1 ALERT
2 ALERT
0 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-2PCO - ellipsoid plot
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Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry
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Appendix C-3. checkCIF-reports for Sb(Ph)4(3PCO).

Structure factors have been supplied for datablock(s) Sb-Ph4-3PCO
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-3PCO
Bond precision: C-C = 0.0036 A
Wavelength=0.71073
Cell:
a=10.0228(4)
b=10.4598(4) c=13.8258(5)
alpha=69.324(1) beta=72.086(1) gamma=83.971(1)
Temperature: 296 K
Calculated
Reported
Volume
1290.34(9)
1290.34(9)
Space group
P -1
P -1
Hall group
-P 1
-P 1
Moiety formula C31 H24 N3 O Sb
C31 H24 N3 O Sb
Sum formula
C31 H24 N3 O Sb
C31 H24 N3 O Sb
Mr
576.29
576.28
Dx,g cm-3
1.483
1.483
Z
2
2
Mu (mm-1)
1.098
1.098
F000
580.0
580.0
F000'
579.01
h,k,lmax
13,13,18
13,13,18
Nref
6224
6218
Tmin,Tmax
0.822,0.897
0.697,0.747
Tmin'
0.798
Correction method= # Reported T Limits:
Tmin=0.697 Tmax=0.747 AbsCorr = MULTI-SCAN
Data completeness= 0.999 Theta(max)= 27.999
R(reflections)= 0.0242(
wR2(reflections)= 0.0585(
5636)
6218)
S = 1.055
Npar= 421
The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.

Alert level C
117

PLAT230_ALERT_2_C Hirshfeld Test Diff for
C11
--C12
.
s.u.
PLAT241_ALERT_2_C High
'MainMol' Ueq as Compared to Neighbors of
Check
PLAT242_ALERT_2_C Low
'MainMol' Ueq as Compared to Neighbors of
Check
PLAT350_ALERT_3_C Short C-H (X0.96,N1.08A) C4
- H4
.
Ang.
And 2 other PLAT350 Alerts
PLAT350_ALERT_3_C Short
Ang.

C-H (X0.96,N1.08A)

C12

6.5
C5
C3
0.83

- H12

.

0.84

PLAT350_ALERT_3_C Short C-H (X0.96,N1.08A) C19
- H19
Ang.
PLAT911_ALERT_3_C Missing FCF Refl Between Thmin & STh/L=
Report

.

0.84

0.600

2

The s.u.'s on the Cell Angles are Equal ..(Note)

0.001

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.

24

Alert level G
PLAT154_ALERT_1_G
Degree
PLAT164_ALERT_4_G
Note
PLAT230_ALERT_2_G
s.u.
PLAT232_ALERT_2_G
s.u.
PLAT883_ALERT_1_G
Do !
PLAT912_ALERT_4_G
Note
PLAT933_ALERT_2_G
Note
PLAT941_ALERT_3_G
Low
PLAT965_ALERT_2_G
Check
PLAT978_ALERT_2_G
Info

Hirshfeld Test Diff for

C1

--C2

.

6.2

Hirshfeld Test Diff (M-X)

Sb1

--O1

.

6.1

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflections Above STh/L=

0.600

4

Number of OMIT Records in Embedded .res File ...

4

Average HKL Measurement Multiplicity ...........

2.9

The SHELXL WEIGHT Optimisation has not Converged

Please

Number C-C Bonds with Positive Residual Density.

12

0 ALERT
0 ALERT
7 ALERT
oversight
10 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

2 ALERT
8 ALERT
deficient
5 ALERT
2 ALERT
0 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020
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Datablock Sb-Ph4-3PCO - ellipsoid plot

Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry
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Appendix C-4. checkCIF-reports for Sb(Ph)4(4PCO).

checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) Sb-Ph4-4PCO
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-4PCO
Bond precision: C-C = 0.0031 A
Wavelength=0.71073
Cell:
a=15.3352(10) b=9.7848(6)
c=19.6576(9)
alpha=90
beta=119.272(4) gamma=90
Temperature: 120 K
Calculated
Reported
Volume
2573.0(3)
2573.0(3)
Space group
P 21/c
P 21/c
Hall group
-P 2ybc
-P 2ybc
Moiety formula C31 H24 N3 O Sb
C31 H24 N3 O Sb
Sum formula
C31 H24 N3 O Sb
C31 H24 N3 O Sb
Mr
576.29
576.28
Dx,g cm-3
1.488
1.428
Z
4
4
Mu (mm-1)
1.101
1.099
F000
1160.0
1068.0
F000'
1158.02
h,k,lmax
23,15,30
22,14,29
Nref
9749
9309
Tmin,Tmax
0.730,0.803
0.683,0.880
Tmin'
0.514
Correction method= # Reported T Limits:
Tmin=0.683 Tmax=0.880 AbsCorr = NUMERICAL
Data completeness= 0.955 Theta(max)= 33.082
R(reflections)= 0.0286(
wR2(reflections)= 0.0678(
7879)
9309)
S = 1.098
Npar= 417
The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.
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Alert level C
DENSD01_ALERT_1_C The ratio of the submitted crystal density and that
calculated from the formula is outside the range 0.99 <> 1.01
Crystal density given
=
1.428
Calculated crystal density =
1.488
PLAT046_ALERT_1_C Reported Z, MW and D(calc) are Inconsistent ....
1.488
Check
PLAT068_ALERT_1_C Reported F000 Differs from Calcd (or Missing)...
Please
Check
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....
2.99
Report
PLAT971_ALERT_2_C Check Calcd Resid. Dens. 1.12A
From C21
1.73
eA-3

Alert level G
PLAT128_ALERT_4_G
Note
PLAT164_ALERT_4_G
Note
PLAT232_ALERT_2_G
s.u.
PLAT883_ALERT_1_G
Do !
PLAT912_ALERT_4_G
Note
PLAT933_ALERT_2_G
Note
PLAT941_ALERT_3_G
Low
PLAT965_ALERT_2_G
Check
PLAT978_ALERT_2_G
Info

Alternate Setting for Input Space Group

P21/c

P21/n

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.
Hirshfeld Test Diff (M-X)

Sb1

--O1

23

.

5.3

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflections Above STh/L=

0.600

400

Number of OMIT Records in Embedded .res File ...

10

Average HKL Measurement Multiplicity ...........

4.5

The SHELXL WEIGHT Optimisation has not Converged

Please

Number C-C Bonds with Positive Residual Density.

15

0 ALERT
0 ALERT
5 ALERT
oversight
9 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

4 ALERT
6 ALERT
deficient
1 ALERT
3 ALERT
0 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-4PCO - ellipsoid plot

121

Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry
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Appendix C-5. checkCIF-reports for the Sb(Ph)4(ECO) μ-oxo-dimer.

checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) Sb-Ph4-ECI-oxo-dimer
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-ECO-oxo-dimer
Bond precision: C-C = 0.0024 A
Wavelength=0.71073
Cell:
a=9.1828(9)
b=10.0829(10) c=13.4714(16)
alpha=111.957(1) beta=103.200(2) gamma=95.405(1)
Temperature: 120 K
Calculated
Reported
Volume
1103.8(2)
1103.8(2)
Space group
P -1
P -1
Hall group
-P 1
-P 1
Moiety formula C46 H40 N4 O7 Sb2
C46 H40 N4 O7 Sb2
Sum formula
C46 H40 N4 O7 Sb2
C46 H40 N4 O7 Sb2
Mr
1004.34
1004.32
Dx,g cm-3
1.511
1.511
Z
1
1
Mu (mm-1)
1.277
1.277
F000
502.0
502.0
F000'
501.02
h,k,lmax
13,14,19
13,14,19
Nref
6741
6688
Tmin,Tmax
0.712,0.795
0.824,1.000
Tmin'
0.282
Correction method= # Reported T Limits:
Tmin=0.824 Tmax=1.000 AbsCorr = NUMERICAL
Data completeness= 0.992 Theta(max)= 30.508
R(reflections)= 0.0188(
wR2(reflections)= 0.0447(
6300)
6688)
S = 1.079
Npar= 348
The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.

Alert level C
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PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....
Report

2.52

Alert level G
PLAT063_ALERT_4_G
mm
PLAT164_ALERT_4_G
Note
PLAT720_ALERT_4_G
Note
PLAT883_ALERT_1_G
Do !
PLAT912_ALERT_4_G
Note
PLAT941_ALERT_3_G
Low
PLAT965_ALERT_2_G
Check
PLAT978_ALERT_2_G
Info

Crystal Size Possibly too Large for Beam Size ..

0.98

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.

20

Number of Unusual/Non-Standard Labels ..........

1

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflections Above STh/L=

0.600

52

Average HKL Measurement Multiplicity ...........

2.6

The SHELXL WEIGHT Optimisation has not Converged

Please

Number C-C Bonds with Positive Residual Density.

16

0 ALERT
0 ALERT
1 ALERT
oversight
8 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

1 ALERT
3 ALERT
deficient
1 ALERT
4 ALERT
0 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-ECO-oxo-dimer - ellipsoid plot
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Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry
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Appendix C-6. checkCIF-reports for Sb(Ph)4(ECO) monomer.

checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) Sb-Ph4-ECO-monomer
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-ECO-monomer
Bond precision: C-C = 0.0080 A
Wavelength=0.71073
Cell:
a=9.7871(6) b=14.9208(9) c=17.6984(11)
alpha=90
beta=94.613(1) gamma=90
Temperature: 120 K
Calculated
Reported
Volume
2576.2(3)
2576.1(3)
Space group
P n
P n
Hall group
P -2yac
P -2yac
Moiety formula C29 H25 N2 O3 Sb
C29 H25 N2 O3 Sb
Sum formula
C29 H25 N2 O3 Sb
C29 H25 N2 O3 Sb
Mr
571.27
571.26
Dx,g cm-3
1.473
1.473
Z
4
4
Mu (mm-1)
1.103
1.103
F000
1152.0
1152.0
F000'
1150.07
h,k,lmax
15,22,27
14,22,26
Nref
19496[ 9759]
9092
Tmin,Tmax
0.815,0.849
0.653,0.747
Tmin'
0.791
Correction method= # Reported T Limits:
Tmin=0.653 Tmax=0.747 AbsCorr = MULTI-SCAN
Data completeness=
Theta(max)= 33.076
0.93/0.47
R(reflections)= 0.0351(
wR2(reflections)= 0.0774(
8454)
9092)
S = 1.193
Npar= 654
The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.

Alert level C
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STRVA01_ALERT_4_C
Flack test results are ambiguous.
From the CIF: _refine_ls_abs_structure_Flack
0.530
From the CIF: _refine_ls_abs_structure_Flack_su
0.040
PLAT220_ALERT_2_C NonSolvent Resd 1 C
Ueq(max) / Ueq(min) Range
Ratio
PLAT220_ALERT_2_C NonSolvent Resd 2 C
Ueq(max) / Ueq(min) Range
Ratio
PLAT222_ALERT_3_C NonSolvent Resd 1 H
Uiso(max)/Uiso(min) Range
Ratio
PLAT342_ALERT_3_C Low Bond Precision on C-C Bonds ...............
Ang.
PLAT907_ALERT_2_C Flack x > 0.5, Structure Needs to be Inverted? .
Check
PLAT914_ALERT_3_C No Bijvoet Pairs in FCF for Non-centro Structure
Check
PLAT971_ALERT_2_C Check Calcd Resid. Dens. 0.85A
From Sb1B
eA-3
And 2 other PLAT971 Alerts
PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.30A

3.2
3.3
6.6
0.00802
0.53
Please
1.73

From C18B

1.51

PLAT971_ALERT_2_C Check Calcd Resid. Dens. 0.64A
From Sb1A
eA-3
PLAT977_ALERT_2_C Check Negative Difference Density on H13A
eA-3
And 2 other PLAT977 Alerts

1.51
-0.41

PLAT977_ALERT_2_C Check Negative Difference Density on H16B
eA-3

-0.32

PLAT977_ALERT_2_C Check Negative Difference Density on H26A
eA-3

-0.35

Alert level G
PLAT083_ALERT_2_G
Why ?
PLAT164_ALERT_4_G
Note
PLAT720_ALERT_4_G
Note
PLAT883_ALERT_1_G
Do !
PLAT912_ALERT_4_G
Note
PLAT933_ALERT_2_G
Note
PLAT941_ALERT_3_G
Low
PLAT961_ALERT_5_G
Check
PLAT978_ALERT_2_G
Info
PLAT992_ALERT_5_G
Check

SHELXL Second Parameter in WGHT

Unusually Large

5.57

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.

5

Number of Unusual/Non-Standard Labels ..........

10

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflections Above STh/L=

0.600

656

Number of OMIT Records in Embedded .res File ...

5

Average HKL Measurement Multiplicity ...........

1.0

Dataset Contains no Negative Intensities .......

Please

Number C-C Bonds with Positive Residual Density.

0

Repd & Actual _reflns_number_gt Values Differ by

8
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0 ALERT
0 ALERT
13 ALERT
oversight
10 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

1 ALERT
12 ALERT
deficient
4 ALERT
4 ALERT
2 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-ECO-monomer - ellipsoid plot

Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry
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Appendix C-7. checkCIF-reports for Sb(Ph)4(MCO).

checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) Sb-Ph4-MCO
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-MCO
Bond precision: C-C = 0.0065 A
Wavelength=0.71073
Cell:
a=17.6451(4) b=10.8777(3) c=28.3876(7)
alpha=90
beta=94.836(1) gamma=90
Temperature: 100 K
Calculated
Reported
Volume
5429.3(2)
5429.3(2)
Space group
P 21/c
P 21/c
Hall group
-P 2ybc
-P 2ybc
Moiety formula C31 H28 N3 O3 Sb
C31 H28 N3 O3 Sb
Sum formula
C31 H28 N3 O3 Sb
C31 H28 N3 O3 Sb
Mr
612.32
612.31
Dx,g cm-3
1.498
1.498
Z
8
8
Mu (mm-1)
1.054
1.054
F000
2480.0
2480.0
F000'
2476.19
h,k,lmax
22,13,35
22,13,35
Nref
11273
11251
Tmin,Tmax
0.863,0.881
0.689,0.745
Tmin'
0.863
Correction method= # Reported T Limits:
Tmin=0.689 Tmax=0.745 AbsCorr = MULTI-SCAN
Data completeness= 0.998 Theta(max)= 26.516
R(reflections)= 0.0447(
wR2(reflections)= 0.1109(
9235)
11251)
S = 1.114
Npar= 750
The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.

Alert level C
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PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....
Report
PLAT222_ALERT_3_C NonSolvent Resd 2 H
Uiso(max)/Uiso(min) Range
Ratio
PLAT245_ALERT_2_C U(iso) H28A
Smaller than U(eq) C28A
by
Ang**2
And 3 other PLAT245 Alerts

3.19
7.7
0.017

PLAT245_ALERT_2_C U(iso) H13B
Ang**2

Smaller than U(eq) C13B

by

0.012

PLAT245_ALERT_2_C U(iso) H21B
Ang**2

Smaller than U(eq) C21B

by

0.014

PLAT245_ALERT_2_C
Ang**2
PLAT906_ALERT_3_C
Check
PLAT911_ALERT_3_C
Report
PLAT971_ALERT_2_C
eA-3
PLAT971_ALERT_2_C
eA-3
PLAT975_ALERT_2_C
eA-3

Smaller than U(eq) C30B

by

0.012

Large K Value in the Analysis of Variance ......

4.570

U(iso) H30B

Missing FCF Refl Between Thmin & STh/L=

0.600

9

Check Calcd Resid. Dens.

1.05A

From C26B

1.94

Check Calcd Resid. Dens.

1.18A

From Sb1A

1.65

Check Calcd Resid. Dens.

0.81A

From O1A

0.57

Alert level G
PLAT083_ALERT_2_G
Why ?
PLAT164_ALERT_4_G
Note
PLAT232_ALERT_2_G
s.u.
PLAT398_ALERT_2_G
Degree
PLAT720_ALERT_4_G
Note
PLAT883_ALERT_1_G
Do !
PLAT912_ALERT_4_G
Note
PLAT933_ALERT_2_G
Note
PLAT965_ALERT_2_G
Check
PLAT978_ALERT_2_G
Info
0 ALERT
0 ALERT
11 ALERT
oversight
10 ALERT

SHELXL Second Parameter in WGHT

Unusually Large

14.34

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.

16

Hirshfeld Test Diff (M-X)
Deviating

C-O-C

Sb1A

--O1A

.

5.3

Angle From 120 for O3B

109.9

Number of Unusual/Non-Standard Labels ..........

16

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflections Above STh/L=

0.600

15

Number of OMIT Records in Embedded .res File ...

10

The SHELXL WEIGHT Optimisation has not Converged

Please

Number C-C Bonds with Positive Residual Density.

2

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or
level G = General information/check it is not something unexpected

1 ALERT type 1 CIF construction/syntax error, inconsistent or missing data

130

14 ALERT
deficient
3 ALERT
3 ALERT
0 ALERT

type 2 Indicator that the structure model may be wrong or
type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-MCO - ellipsoid plot

Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry

Appendix C-8. checkCIF-reports for Sb(Ph)4(TCO) polymorph 1.
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checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) done_Sb-Ph4-TCOpolymorph-1
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-TCO-polymorph-1
Bond precision: C-C = 0.0045 A
Wavelength=0.71073
Cell:
a=14.6709(7) b=9.8468(5)
c=18.3414(9)
alpha=90
beta=111.994(1) gamma=90
Temperature: 120 K
Calculated
Reported
Volume
2456.8(2)
2456.8(2)
Space group
P 21/c
P 21/c
Hall group
-P 2ybc
-P 2ybc
Moiety formula C27 H21 N3 O S Sb
C27 H21 N3 O S Sb
Sum formula
C27 H21 N3 O S Sb
C27 H21 N3 O S Sb
Mr
557.29
557.28
Dx,g cm-3
1.507
1.507
Z
4
4
Mu (mm-1)
1.232
1.232
F000
1116.0
1116.0
F000'
1114.48
h,k,lmax
18,12,23
18,12,23
Nref
5478
5476
Tmin,Tmax
0.814,0.840
0.894,0.931
Tmin'
0.814
Correction method= # Reported T Limits:
Tmin=0.894 Tmax=0.931 AbsCorr = NUMERICAL
Data completeness= 1.000 Theta(max)= 27.202
R(reflections)= 0.0308(
wR2(reflections)= 0.0764(
4595)
5476)
S = 1.033
Npar= 391
The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
Click on the hyperlinks for more details of the test.

Alert level C
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PLAT094_ALERT_2_C
Report
PLAT420_ALERT_2_C
Check
PLAT973_ALERT_2_C
eA-3
PLAT975_ALERT_2_C
eA-3

Ratio of Maximum / Minimum Residual Density ....
D-H Without Acceptor

N3

--H3B

Check Calcd Positive Resid. Density on
Check Calcd Resid. Dens.

0.84A

2.03

.

Please

Sb1

1.03

From C8

0.68

Alert level G
PLAT007_ALERT_5_G
Report
PLAT164_ALERT_4_G
Note
PLAT171_ALERT_4_G
Report
PLAT301_ALERT_3_G
Note
PLAT343_ALERT_2_G
Check
PLAT432_ALERT_2_G
Ang.

Number of Unrefined Donor-H Atoms ..............

4

Nr. of Refined C-H H-Atoms in Heavy-Atom Struct.

14

The CIF-Embedded .res File Contains EADP Records

6

Main Residue
Unusual sp?

Disorder ..............(Resd

)

24%

Angle Range in Main Residue for

C8

Short Inter X...Y Contact

C18

..N2A

1-x,-1/2+y,1/2-z
Check
PLAT720_ALERT_4_G
Note
PLAT883_ALERT_1_G
Do !
PLAT910_ALERT_3_G
Note
PLAT912_ALERT_4_G
Note
PLAT933_ALERT_2_G
Note
PLAT978_ALERT_2_G
Info

1

2.93
=

2_645

Number of Unusual/Non-Standard Labels ..........

2

No Info/Value for _atom_sites_solution_primary .

Please

Missing # of FCF Reflection(s) Below Theta(Min).

1

Missing # of FCF Reflections Above STh/L=

0.600

2

Number of OMIT Records in Embedded .res File ...

1

Number C-C Bonds with Positive Residual Density.

2

0 ALERT
0 ALERT
4 ALERT
oversight
12 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

1 ALERT
8 ALERT
deficient
2 ALERT
4 ALERT
1 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check

PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-TCO-polymorph-1 - ellipsoid plot
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Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry
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Appendix C-9. checkCIF-reports for Sb(Ph)4(TCO) polymorph 2.

checkCIF/PLATON (basic structural check)
Structure factors have been supplied for datablock(s) Sb-Ph4-TCO_polymorph-2
THIS REPORT IS FOR GUIDANCE ONLY. IF USED AS PART OF A REVIEW
PROCEDURE FOR PUBLICATION, IT SHOULD NOT REPLACE THE
EXPERTISE OF AN EXPERIENCED CRYSTALLOGRAPHIC REFEREE.
No syntax errors found.
Please wait while processing ....
report

CIF dictionary
Interpreting this

Structure factor report

Datablock: Sb-Ph4-TCO_polymorph-2
Bond precision: C-C = 0.0152 A
Wavelength=0.71073
Cell:
a=24.517(4) b=24.448(4)
c=32.958(5)
alpha=90
beta=101.670(2) gamma=90
Temperature: 100 K
Calculated
Reported
Volume
19346(5)
19346(5)
Space group
C c
C c
Hall group
C -2yc
C -2yc
Moiety formula C27 H22 N3 O S Sb
C27 H22 N3 O S Sb
Sum formula
C27 H22 N3 O S Sb
C216 H176 N24 O8 S8 Sb8
Mr
558.30
4466.28
Dx,g cm-3
1.533
1.533
Z
32
4
Mu (mm-1)
1.252
1.252
F000
8960.0
8960.0
F000'
8947.83
h,k,lmax
33,33,45
33,33,45
Nref
53786[ 26901]
49604
Tmin,Tmax
0.837,0.915
0.626,0.746
Tmin'
0.837
Correction method= # Reported T Limits:
Tmin=0.626 Tmax=0.746 AbsCorr = MULTI-SCAN
Data completeness=
Theta(max)= 29.483
1.84/0.92
R(reflections)= 0.0569(
wR2(reflections)= 0.1472(
41772)
49604)
S = 1.047
Npar= 2379
The following ALERTS were generated. Each ALERT has the format
test-name_ALERT_alert-type_alert-level.
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Click on the hyperlinks for more details of the test.

Alert level A
PLAT213_ALERT_2_A Atom C24D
has ADP max/min Ratio .....
prolat
PLAT213_ALERT_2_A Atom C18F
has ADP max/min Ratio .....
oblate
PLAT971_ALERT_2_A Check Calcd Resid. Dens. 1.59A
From N1D
eA-3
And 7 other PLAT971 Alerts

5.3
5.9
5.81

PLAT971_ALERT_2_A Check Calcd Resid. Dens.
eA-3

1.56A

From C21B

5.72

PLAT971_ALERT_2_A Check Calcd Resid. Dens.
eA-3

1.61A

From C17Q

5.42

PLAT971_ALERT_2_A Check Calcd Resid. Dens.
eA-3

1.56A

From N1C

5.25

PLAT971_ALERT_2_A Check Calcd Resid. Dens.
eA-3

1.49A

From C11E

5.21

PLAT971_ALERT_2_A Check Calcd Resid. Dens.
eA-3

1.51A

From N1F

5.12

PLAT971_ALERT_2_A Check Calcd Resid. Dens.
eA-3

1.58A

From C17A

4.91

PLAT971_ALERT_2_A Check Calcd Resid. Dens.
eA-3

1.53A

From C11H

4.84

Alert level B
PLAT097_ALERT_2_B Large Reported Max. (Positive) Residual Density
eA-3
PLAT971_ALERT_2_B Check Calcd Resid. Dens. 1.66A
From C13E
eA-3
And 3 other PLAT971 Alerts

5.68

PLAT971_ALERT_2_B Check Calcd Resid. Dens.
eA-3

1.80A

From C19A

2.88

PLAT971_ALERT_2_B Check Calcd Resid. Dens.
eA-3

1.79A

From C19Q

2.73

PLAT971_ALERT_2_B Check Calcd Resid. Dens.
eA-3

1.80A

From C25D

2.54

2.89

Alert level C
DIFMX02_ALERT_1_C The maximum difference density is > 0.1*ZMAX*0.75
The relevant atom site should be identified.
PLAT094_ALERT_2_C Ratio of Maximum / Minimum Residual Density ....
Report
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2.76

PLAT213_ALERT_2_C Atom C6C
has ADP max/min Ratio .....
prolat
PLAT234_ALERT_4_C Large Hirshfeld Difference C19B
--C20B
.
Ang.
PLAT234_ALERT_4_C Large Hirshfeld Difference C6C
--C7C
.
Ang.
PLAT342_ALERT_3_C Low Bond Precision on C-C Bonds ...............
Ang.
PLAT911_ALERT_3_C Missing FCF Refl Between Thmin & STh/L=
0.600
Report
PLAT971_ALERT_2_C Check Calcd Resid. Dens. 1.76A
From C13H
eA-3
And 8 other PLAT971 Alerts

3.4
0.18
0.17
0.01521
14
2.39

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.78A

From C19B

2.27

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.67A

From C19F

2.15

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.66A

From C7C

2.04

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.95A

From C2A

1.72

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.93A

From C2E

1.70

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.82A

From C2H

1.69

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3

1.80A

From C2Q

1.68

PLAT971_ALERT_2_C Check Calcd Resid. Dens.
eA-3
PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3
And 8 other PLAT972 Alerts

1.93A

From C2F

1.54

0.60A

From Sb1B

-1.96

PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3

0.74A

From Sb1C

-1.85

PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3

0.72A

From Sb1D

-1.83

PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3

0.75A

From Sb1Q

-1.71

PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3

0.78A

From Sb1F

-1.67
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PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3

0.61A

From Sb1E

-1.58

PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3

0.61A

From Sb1F

-1.55

PLAT972_ALERT_2_C Check Calcd Resid. Dens.
eA-3

0.78A

From Sb1C

-1.53

PLAT972_ALERT_2_C Check Calcd Resid. Dens. 0.77A
From Sb1B
eA-3
PLAT977_ALERT_2_C Check Negative Difference Density on H9H
eA-3
PLAT977_ALERT_2_C Check Negative Difference Density on H23E
eA-3

-1.51
-0.31
-0.35

Alert level G
FORMU01_ALERT_1_G There is a discrepancy between the atom counts in the
_chemical_formula_sum and _chemical_formula_moiety. This is
usually due to the moiety formula being in the wrong format.
Atom count from _chemical_formula_sum:
C216 H176 N24 O8 S8 Sb8
Atom count from _chemical_formula_moiety:C27 H22 N3 O1 S1 Sb1
PLAT007_ALERT_5_G Number of Unrefined Donor-H Atoms ..............
16
Report
PLAT045_ALERT_1_G Calculated and Reported Z Differ by a Factor ...
8.00
Check
PLAT083_ALERT_2_G SHELXL Second Parameter in WGHT Unusually Large
137.89
Why ?
PLAT720_ALERT_4_G Number of Unusual/Non-Standard Labels ..........
16
Note
PLAT883_ALERT_1_G No Info/Value for _atom_sites_solution_primary .
Please
Do !
PLAT912_ALERT_4_G Missing # of FCF Reflections Above STh/L= 0.600
1520
Note
PLAT933_ALERT_2_G Number of OMIT Records in Embedded .res File ...
15
Note
PLAT965_ALERT_2_G The SHELXL WEIGHT Optimisation has not Converged
Please
Check
PLAT978_ALERT_2_G Number C-C Bonds with Positive Residual Density.
0
Info
PLAT992_ALERT_5_G Repd & Actual _reflns_number_gt Values Differ by
2
Check
10 ALERT
5 ALERT
27 ALERT
oversight
11 ALERT

level A = Most likely a serious problem - resolve or explain
level B = A potentially serious problem, consider carefully
level C = Check. Ensure it is not caused by an omission or

4 ALERT
41 ALERT
deficient
2 ALERT
4 ALERT
2 ALERT

type 1 CIF construction/syntax error, inconsistent or missing data
type 2 Indicator that the structure model may be wrong or

level G = General information/check it is not something unexpected

type 3 Indicator that the structure quality may be low
type 4 Improvement, methodology, query or suggestion
type 5 Informative message, check
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PLATON version of 04/06/2020; check.def file version of 02/06/2020

Datablock Sb-Ph4-TCO_polymorph-2 - ellipsoid plot

Download CIF editor (publCIF) from the IUCr
Download CIF editor (enCIFer) from the CCDC
Test a new CIF entry
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Appendix D. Biological Activity Studies Data.

Appendix D-1. Raw data and statistical analysis of Sb(Ph)4(ACO) in the first round of inhibition zone measurements.
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Appendix D-2. Raw data and statistical analysis of Sb(Ph)4(ECO) in the first round of inhibition zone measurements.
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Appendix D-3. Raw data and statistical analysis of Sb(Ph)4(TCO) in the first round of inhibition zone measurements.
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Appendix D-4. Statistical analysis of the second round of inhibition zone measurements for antimicrobial testing.
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DMSO gradient_5_27_2020
OD600

1.5
1
0.5
0
S. aureus
0%

1%

2%

E. coli
Organism
3%

4%

5%

6%

P. aeruginosa
7%

8%

9%

Appendix D-5. Effect of DMSO concentration on MIC of studied selected strains.
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